Patent Grant
11904036
The present disclosure generally relates to stable, clear personal cleansing compositions which are substantially free of surfactants containing sulfates and are formulated with anionic surfactants, amphoteric or amphoteric surfactants, cationic deposition polymers and a low level of inorganic salt.
Most commercial cleansing compositions, such as shampoo compositions, comprise sulfate-based surfactant systems because of their effectiveness in generating high lather volume and good lather stability and cleaning. However, some consumers may prefer a shampoo composition that is substantially free of sulfate-based surfactant systems. In addition, sulfate free shampoos users prefer high conditioning shampoos because higher conditioning shampoos feel less stripping to the hair. Conditioning shampoos based on sulfate based surfactant systems typically contain cationic conditioning polymers to form coacervate with the sulfate based surfactant system during use. However, it can be difficult to use non-sulfate based surfactants in liquid shampoos because it can be difficult to formulate a composition that has acceptable lather volume, cleansing, conditioning benefit, stability, and clarity. One common problem using certain cationic conditioning polymers in products that are substantially free of sulfate containing surfactants can result in instability. In particular, a second hydrophobic phase known as surfactant-polymer coacervate can be formed in the composition (rather than the desired formation during use) as the result of interaction between the cationic polymer and the non-sulfate anionic surfactants. This is observed by the consumer as a cloudy product or a product with a precipitated layer, which is not consumer preferred. Presence of coacervate in the cleaning compositions can separate upon storage, causing inconsistent performance in use. Thus, there is a need to formulate stable shampoo products comprising anionic non-sulfated surfactants, amphoteric surfactant and cationic polymers without forming the coacervate phase in the product, yet a coacervate is formed when diluted with water during use, such as during shampooing, delivering desired wet conditioning benefits on hair. There is also a need to be able to formulate versions of these products without the use of a rheology modifier or a thickener. This need is even more important for products that have low viscosity, such as foamed products delivered via an aerosol device or a mechanical former, such as a pump. The viscosity of such compositions may be significantly lower than the typical liquid shampoos.
It has been surprisingly found that stable products that exhibit good spreadability and good conditioning can be achieved.
A personal care composition comprising: from about 3 wt % and from about 35 wt % of an anionic surfactant; from about 3 wt % to about 15% of an amphoteric surfactant; from about 0.01 wt % to about 2 wt % cationic polymer; from about 0 wt % to about 1.0 wt % of an inorganic salt; an aqueous carrier, wherein the composition is substantially free of sulfate based surfactant wherein the composition has a % T value of greater than about 80.
A cleansing composition comprising: from about 5 wt % to about 35 wt % of an anionic surfactant selected from amino acid based surfactants; from about 0.01 wt % to about 2 wt % cationic polymer; from about 0 wt % to about 1.0 wt % of inorganic salts; an aqueous carrier, wherein the composition is substantially free of sulfate based surfactant and wherein the composition has a % T value of greater than about 80.
While the specification concludes with claims particularly pointing out and distinctly claiming the invention, it is believed that the present disclosure will be better understood from the following description.
As used herein, the term “fluid” includes liquids and gels.
As used herein, the articles including “a” and “an” when used in a claim, are understood to mean one or more of what is claimed or described.
As used herein, “comprising” means that other steps and other ingredients which do not affect the end result can be added. This term encompasses the terms “consisting of” and “consisting essentially of”.
As used herein, “mixtures” is meant to include a simple combination of materials and any compounds that may result from their combination.
As used herein, “molecular weight” or “M.Wt.” refers to the weight average molecular weight unless otherwise stated. Molecular weight is measured using industry standard method, gel permeation chromatography (“GPC”). The molecular weight has units of grams/mol.
As used herein, “cleansing composition” includes products such as shampoos, conditioners, conditioning shampoos, shower gels, liquid hand cleansers, facial cleansers, and other surfactant-based liquid compositions.
As used herein, the terms “include,” “includes,” and “including,” are meant to be non-limiting and are understood to mean “comprise,” “comprises,” and “comprising,” respectively.
All percentages, parts and ratios are based upon the total weight of the compositions of the present invention, unless otherwise specified. All such weights as they pertain to listed ingredients are based on the active level and, therefore, do not include carriers or by-products that may be included in commercially available materials.
Unless otherwise noted, all component or composition levels are in reference to the active portion of that component or composition, and are exclusive of impurities, for example, residual solvents or by-products, which may be present in commercially available sources of such components or compositions.
It should be understood that every maximum numerical limitation given throughout this specification includes every lower numerical limitation, as if such lower numerical limitations were expressly written herein. Every minimum numerical limitation given throughout this specification will include every higher numerical limitation, as if such higher numerical limitations were expressly written herein. Every numerical range given throughout this specification will include every narrower numerical range that falls within such broader numerical range, as if such narrower numerical ranges were all expressly written herein.
Cleansing Compositions
Typically, inorganic salt (NaCl) is added to sulfated surfactant based cleansing formulations to thicken the product. It has been surprisingly found that adding inorganic salt to the formulas that are substantially free of sulfate containing surfactants and/or using high inorganic salt containing sulfate free surfactants in the presence of cationic conditioning polymer can cause product instability due to formation of a gel-like surfactant-polymer complex known as coacervate in the composition. By maintaining low inorganic salt (NaCl) concentration in formulas (from about 0 to about 1 wt %) the instability issue in sulfate free formulations comprising anionic surfactant and high molecular weight cationic polymer is resolved. The solution is to avoid or minimize adding extra inorganic salt to the formula and/or by using low inorganic salt containing raw materials. For example, commercially available sulfate free surfactants such as disodium cocoyl glutamate typically comes with high levels of inorganic salt such as 5% or higher. Amphoteric surfactant such as betaines or sultaines also typically come with high levels of inorganic salt such as NaCl. Use of these high salt containing raw materials in sulfate-free surfactant based cleaning formulations in excess of about 1% total NaCl in the formulation can cause formation of undesired coacervate in the product. If the inorganic salt level is lowered in the surfactant raw materials so that total salt in the composition is less than about 1% or lower, a stable 1-phase clear product can be formulated. Whereas, if the regular material with high inorganic salt is used, the product is cloudy, 2-phase, and unstable. The cloudy 2-phase product is likely the result of a gel-like precipitate formed between the anionic surfactant and high molecular weight cationic polymer known as coacervate. The solution described herein prevents the undesired coacervate formation in product while on the shelf (before use), and yet forms coacervate when needed, during use after dilution, to deliver consumer desired wet conditioning.
The formation of coacervate upon dilution of the cleansing composition with water, rather than while in the bottle on the shelf, is important to improving wet conditioning and deposition of various conditioning actives, especially those that have small droplet sizes (i.e., <2 microns). To form coacervate at the right time (upon dilution during use), cleansing compositions comprising anionic surfactants substantially free of sulfates, amphoteric surfactants and cationic polymers should maintain an inorganic salt level of less than 1%.
The cleansing composition is clear prior to dilution with water. The term “clear” or “transparent” as used herein, means that the compositions have a percent transparency (% T) of at least about 80% transmittance at 600 nm. The % T can be at 600 nm from about 75% to about 100%, from about 80% to about 100%, from about 85% to about 100%, from about 90% to about 100%, from about 95% to about 100%.
A. Surfactant
The cleansing compositions described herein can include one or more surfactants in the surfactant system. The one or more surfactants can be substantially free of sulfate-based surfactants. As can be appreciated, surfactants provide a cleaning benefit to soiled articles such as hair, skin, and hair follicles by facilitating the removal of oil and other soils. Surfactants generally facilitate such cleaning due to their amphiphilic nature which allows for the surfactants to break up, and form micelles around, oil and other soils which can then be rinsed out, thereby removing them from the soiled article. Suitable surfactants for a cleansing composition can include anionic moieties to allow for the formation of a coacervate with a cationic polymer. The surfactant can be selected from anionic surfactants, amphoteric surfactants, zwitterionic surfactants, non-ionic surfactants, and combinations thereof.
Cleansing compositions typically employ sulfate-based surfactant systems (such as, but not limited to, sodium lauryl sulfate) because of their effectiveness in lather production, stability, clarity and cleansing. The cleansing compositions described herein are substantially free of sulfate-based surfactants. “Substantially free” of sulfate based surfactants as used herein means from about 0 wt % to about 3 wt %, alternatively from about 0 wt % to about 2 wt %, alternatively from about 0 wt % to about 1 wt %, alternatively from about 0 wt % to about 0.5 wt %, alternatively from about 0 wt % to about 0.25 wt %, alternatively from about 0 wt % to about 0.1 wt %, alternatively from about 0 wt % to about 0.05 wt %, alternatively from about 0 wt % to about 0.01 wt %, alternatively from about 0 wt % to about 0.001 wt %, and/or alternatively free of sulfates. As used herein, “free of” means 0 wt %.
Additionally, the surfactant systems described herein have from about 0 wt % to about 1 wt % of inorganic salts.
Suitable surfactants that are substantially free of sulfates can include sodium, ammonium or potassium salts of isethionates; sodium, ammonium or potassium salts of sulfonates; sodium, ammonium or potassium salts of ether sulfonates; sodium, ammonium or potassium salts of sulfosuccinates; sodium, ammonium or potassium salts of sulfoacetates; sodium, ammonium or potassium salts of glycinates; sodium, ammonium or potassium salts of sarcosinates; sodium, ammonium or potassium salts of glutamates; sodium, ammonium or potassium salts of alaninates; sodium, ammonium or potassium salts of carboxylates; sodium, ammonium or potassium salts of taurates; sodium, ammonium or potassium salts of phosphate esters; and combinations thereof.
The concentration of the surfactant in the composition should be sufficient to provide the desired cleaning and lather performance. The cleansing composition can comprise a total surfactant level of from about 6% to about 50%, from about 5% to about 35%, a total surfactant level of from about 10% to about 50%, by weight, from about 15% to about 45%, by weight, from about 20% to about 40%, by weight, from about 22% to about 35%, and/or from about 25% to about 30%.
The surfactant system can include one or more amino acid based anionic surfactants. Non-limiting examples of amino acid based anionic surfactants can include sodium, ammonium or potassium salts of acyl glycinates; sodium, ammonium or potassium salts of acyl sarcosinates; sodium, ammonium or potassium salts of acyl glutamates; sodium, ammonium or potassium salts of acyl alaninates and combinations thereof.
The amino acid based anionic surfactant can be a glutamate, for instance an acyl glutamate. The composition can comprise an acyl glutamate level from about 2% to about 22%, by weight, from about 3% to about 19%, by weight, 4% to about 17%, by weight, and/or from about 5% to about 15%, by weight.
Non-limiting examples of acyl glutamates can be selected from the group consisting of sodium cocoyl glutamate, disodium cocoyl glutamate, ammonium cocoyl glutamate, diammonium cocoyl glutamate, sodium lauroyl glutamate, disodium lauroyl glutamate, sodium cocoyl hydrolyzed wheat protein glutamate, disodium cocoyl hydrolyzed wheat protein glutamate, potassium cocoyl glutamate, dipotassium cocoyl glutamate, potassium lauroyl glutamate, dipotassium lauroyl glutamate, potassium cocoyl hydrolyzed wheat protein glutamate, dipotassium cocoyl hydrolyzed wheat protein glutamate, sodium capryloyl glutamate, disodium capryloyl glutamate, potassium capryloyl glutamate, dipotassium capryloyl glutamate, sodium undecylenoyl glutamate, disodium undecylenoyl glutamate, potassium undecylenoyl glutamate, dipotassium undecylenoyl glutamate, disodium hydrogenated tallow glutamate, sodium stearoyl glutamate, disodium stearoyl glutamate, potassium stearoyl glutamate, dipotassium stearoyl glutamate, sodium myristoyl glutamate, disodium myristoyl glutamate, potassium myristoyl glutamate, dipotassium myristoyl glutamate, sodium cocoyl/hydrogenated tallow glutamate, sodium cocoyl/palmoyl/sunfloweroyl glutamate, sodium hydrogenated tallowoyl Glutamate, sodium olivoyl glutamate, disodium olivoyl glutamate, sodium palmoyl glutamate, disodium palmoyl Glutamate, TEA-cocoyl glutamate, TEA-hydrogenated tallowoyl glutamate, TEA-lauroyl glutamate, and mixtures thereof.
The amino acid based anionic surfactant can be an alaninate, for instance an acyl alaninate. Non-limiting example of acyl alaninates can include sodium cocoyl alaninate, sodium lauroyl alaninate, sodium N-dodecanoyl-1-alaninate and combination thereof. The composition can comprise an acyl alaninate level from about 2% to about 20%, by weight, from about 7% to about 15%, by weight, and/or from about 8% to about 12%, by weight.
The amino acid based anionic surfactant can be a sarcosinate, for instance an acyl sarcosinate. Non-limiting examples of sarcosinates can be selected from the group consisting of sodium lauroyl sarcosinate, sodium cocoyl sarcosinate, sodium myristoyl sarcosinate, TEA-cocoyl sarcosinate, ammonium cocoyl sarcosinate, ammonium lauroyl sarcosinate, dimer dilinoleyl bis-lauroylglutamate/lauroylsarcosinate, disodium lauroamphodiacetate lauroyl sarcosinate, isopropyl lauroyl sarcosinate, potassium cocoyl sarcosinate, potassium lauroyl sarcosinate, sodium cocoyl sarcosinate, sodium lauroyl sarcosinate, sodium myristoyl sarcosinate, sodium oleoyl sarcosinate, sodium palmitoyl sarcosinate, TEA-cocoyl sarcosinate, TEA-lauroyl sarcosinate, TEA-oleoyl sarcosinate, TEA-palm kernel sarcosinate, and combinations thereof.
The amino acid based anionic surfactant can be a glycinate for instance an acyl glycinate. Non-limiting example of acyl glycinates can include sodium cocoyl glycinate, sodium lauroyl glycinate and combination thereof.
The composition can contain additional anionic surfactants selected from the group consisting of sulfosuccinates, isethionates, sulfonates, sulfoacetates, glucose carboxylates, alkyl ether carboxylates, acyl taurates, and mixture thereof.
Non-limiting examples of sulfosuccinate surfactants can include disodium N-octadecyl sulfosuccinate, disodium lauryl sulfosuccinate, diammonium lauryl sulfosuccinate, sodium lauryl sulfosuccinate, disodium laureth sulfosuccinate, tetrasodium N-(1,2-dicarboxyethyl)-N-octadecyl sulfosuccinate, diamyl ester of sodium sulfosuccinic acid, dihexyl ester of sodium sulfosuccinic acid, dioctyl esters of sodium sulfosuccinic acid, and combinations thereof. The composition can comprise a sulfosuccinate level from about 2% to about 22%, by weight, from about 3% to about 19%, by weight, 4% to about 17%, by weight, and/or from about 5% to about 15%, by weight.
Suitable isethionate surfactants can include the reaction product of fatty acids esterified with isethionic acid and neutralized with sodium hydroxide. Suitable fatty acids for isethionate surfactants can be derived from coconut oil or palm kernel oil including amides of methyl tauride. Non-limiting examples of isethionates can be selected from the group consisting of sodium lauroyl methyl isethionate, sodium cocoyl isethionate, ammonium cocoyl isethionate, sodium hydrogenated cocoyl methyl isethionate, sodium lauroyl isethionate, sodium cocoyl methyl isethionate, sodium myristoyl isethionate, sodium oleoyl isethionate, sodium oleyl methyl isethionate, sodium palm kerneloyl isethionate, sodium stearoyl methyl isethionate, and mixtures thereof.
Non-limiting examples of sulfonates can include alpha olefin sulfonates, linear alkylbenzene sulfonates, sodium laurylglucosides hydroxypropylsulfonate and combination thereof.
Non-limiting examples of sulfoacetates can include sodium lauryl sulfoacetate, ammonium lauryl sulfoacetate and combination thereof.
Non-limiting example of glucose carboxylates can include sodium lauryl glucoside carboxylate, sodium cocoyl glucoside carboxylate and combinations thereof.
Non-limiting example of alkyl ether carboxylate can include sodium laureth-4 carboxylate, laureth-5 carboxylate, laureth-13 carboxylate, sodium C12-13 pareth-8 carboxylate, sodium C12-15 pareth-8 carboxylate and combination thereof.
Non-limiting example of acyl taurates can include sodium methyl cocoyl taurate, sodium methyl lauroyl taurate, sodium methyl oleoyl taurate and combination thereof.
The surfactant system may further comprise one or more amphoteric surfactants and the amphoteric surfactant can be selected from the group consisting of betaines, sultaines, hydroxysultanes, amphohydroxypropyl sulfonates, alkyl amphoactates, alkyl amphodiacetates and combination thereof.
Examples of betaine amphoteric surfactants can include coco dimethyl carboxymethyl betaine, cocoamidopropyl betaine (CAPB), cocobetaine, lauryl amidopropyl betaine (LAPB), oleyl betaine, lauryl dimethyl carboxymethyl betaine, lauryl dimethyl alphacarboxyethyl betaine, cetyl dimethyl carboxymethyl betaine, lauryl bis-(2-hydroxyethyl) carboxymethyl betaine, stearyl bis-(2-hydroxypropyl) carboxymethyl betaine, oleyl dimethyl gamma-carboxypropyl betaine, lauryl bis-(2-hydroxypropyl)alpha-carboxyethyl betaine, and mixtures thereof. Examples of sulfobetaines can include coco dimethyl sulfopropyl betaine, stearyl dimethyl sulfopropyl betaine, lauryl dimethyl sulfoethyl betaine, lauryl bis-(2-hydroxyethyl) sulfopropyl betaine and mixtures thereof.
Non-limiting example of alkylamphoacetates can include sodium cocoyl amphoacetate, sodium lauroyl amphoacetate and combination thereof.
The amphoteric surfactant can comprise cocamidopropyl betaine (CAPB), lauramidopropyl betaine (LAPB), and combinations thereof.
The cleansing composition can comprise an amphoteric surfactant level from about 0.5 wt % to about 20 wt %, from about 1 wt % to about 15 wt %, from about 2 wt % to about 13 wt %, from about 3 wt % to about 15 wt %, and/or from about 5 wt % to about 10 wt %.
The surfactant system can have a weight ratio of anionic surfactant to amphoteric surfactant from about 1:5 to about 10:1, from about 1:2 to about 7:1, from 1:1 to about 5:1, and/or from about 2:1 to about 4:1. The surfactant system can have a weight ratio of anionic surfactant to amphoteric surfactant greater than 1:1, greater than 3:2, greater than 9:5, and/or greater than 2:1.
The surfactant system may further comprise one or more non-ionic surfactants and the non-ionic surfactant can be selected from the group consisting alkyl polyglucoside, alkyl glycoside, acyl glucamide and mixture thereof. Non-limiting examples of alkyl glucosides can include decyl glucoside, cocoyl glucoside, lauroyl glucoside and combination thereof.
Non-limiting examples of acyl glucamide can include lauroyl/myristoyl methyl glucamide, capryloyl/caproyl methyl glucamide, lauroyl/myristoyl methyl glucamide, cocoyl methyl glucamide and combinations thereof.
B. Cationic Polymer
A cleansing composition can include a cationic polymer to allow formation of a coacervate. As can be appreciated, the cationic charge of a cationic polymer can interact with an anionic charge of a surfactant to form the coacervate. Suitable cationic polymers can include: (a) a cationic guar polymer, (b) a cationic non-guar galactomannan polymer, (c) a cationic starch polymer, (d) a cationic copolymer of acrylamide monomers and cationic monomers, (e) a synthetic, non-crosslinked, cationic polymer, which may or may not form lyotropic liquid crystals upon combination with the detersive surfactant, and (f) a cationic cellulose polymer. In certain examples, more than one cationic polymer can be included.
A cationic polymer can be included by weight of the cleansing composition at about 0.05% to about 3%, about 0.075% to about 2.0%, or at about 0.1% to about 1.0%. Cationic polymers can have cationic charge densities of about 0.9 meq/g or more, about 1.2 meq/g or more, and about 1.5 meq/g or more. However, cationic charge density can also be about 7 meq/g or less and alternatively about 5 meq/g or less. The charge densities can be measured at the pH of intended use of the cleansing composition. (e.g., at about pH 3 to about pH 9; or about pH 4 to about pH 8). The average molecular weight of cationic polymers can generally be between about 10,000 and 10 million, between about 50,000 and about 5 million, and between about 100,000 and about 3 million, and between about 300,000 and about 3 million and between about 100,000 and about 2.5 million. Low molecular weight cationic polymers can be used. Low molecular weight cationic polymers can have greater translucency in the liquid carrier of a cleansing composition. The cationic polymer can be a single type, such as the cationic guar polymer guar hydroxypropyltrimonium chloride having a weight average molecular weight of about 2.5 million g/mol or less, and the cleansing composition can have an additional cationic polymer of the same or different types.
Cationic Guar Polymer
The cationic polymer can be a cationic guar polymer, which is a cationically substituted galactomannan (guar) gum derivative. Suitable guar gums for guar gum derivatives can be obtained as a naturally occurring material from the seeds of the guar plant. As can be appreciated, the guar molecule is a straight chain mannan which is branched at regular intervals with single membered galactose units on alternative mannose units. The mannose units are linked to each other by means of β(1-4) glycosidic linkages. The galactose branching arises by way of an α(1-6) linkage. Cationic derivatives of the guar gums can be obtained through reactions between the hydroxyl groups of the polygalactomannan and reactive quaternary ammonium compounds. The degree of substitution of the cationic groups onto the guar structure can be sufficient to provide the requisite cationic charge density described above.
A cationic guar polymer can have a weight average molecular weight (“M.Wt.”) of less than about 3 million g/mol, and can have a charge density from about 0.05 meq/g to about 2.5 meq/g. Alternatively, the cationic guar polymer can have a weight average M.Wt. of less than 1.5 million g/mol, from about 150 thousand g/mol to about 1.5 million g/mol, from about 200 thousand g/mol to about 1.5 million g/mol, from about 300 thousand g/mol to about 1.5 million g/mol, and from about 700,000 thousand g/mol to about 1.5 million g/mol. The cationic guar polymer can have a charge density from about 0.2 meq/g to about 2.2 meq/g, from about 0.3 meq/g to about 2.0 meq/g, from about 0.4 meq/g to about 1.8 meq/g; and from about 0.5 meq/g to about 1.7 meq/g.
A cationic guar polymer can have a weight average M.Wt. of less than about 1 million g/mol, and can have a charge density from about 0.1 meq/g to about 2.5 meq/g. A cationic guar polymer can have a weight average M.Wt. of less than 900 thousand g/mol, from about 150 thousand to about 800 thousand g/mol, from about 200 thousand g/mol to about 700 thousand g/mol, from about 300 thousand to about 700 thousand g/mol, from about 400 thousand to about 600 thousand g/mol, from about 150 thousand g/mol to about 800 thousand g/mol, from about 200 thousand g/mol to about 700 thousand g/mol, from about 300 thousand g/mol to about 700 thousand g/mol, and from about 400 thousand g/mol to about 600 thousand g/mol. A cationic guar polymer has a charge density from about 0.2 meq/g to about 2.2 meq/g, from about 0.3 meq/g to about 2.0 meq/g, from about 0.4 meq/g to about 1.8 meq/g; and from about 0.5 meq/g to about 1.5 meq/g.
A cleansing composition can include from about 0.01% to less than about 0.7%, by weight of the cleansing composition of a cationic guar polymer, from about 0.04% to about 0.55%, by weight, from about 0.08% to about 0.5%, by weight, from about 0.16% to about 0.5%, by weight, from about 0.2% to about 0.5%, by weight, from about 0.3% to about 0.5%, by weight, and from about 0.4% to about 0.5%, by weight.
The cationic guar polymer can be formed from quaternary ammonium compounds which conform to general Formula II:
wherein where R3, R4 and R5 are methyl or ethyl groups; and R6 is either an epoxyalkyl group of the general Formula III:
or R6 is a halohydrin group of the general Formula IV:
wherein R7 is a C1 to C3 alkylene; X is chlorine or bromine, and Z is an anion such as Cl—, Br—, I— or HSO4—.
Suitable cationic guar polymers can conform to the general formula V:
wherein R8 is guar gum; and wherein R4, R5, R6 and R7 are as defined above; and wherein Z is a halogen. Suitable cationic guar polymers can conform to Formula VI:
Suitable cationic guar polymers can also include cationic guar gum derivatives, such as guar hydroxypropyltrimonium chloride. Suitable examples of guar hydroxypropyltrimonium chlorides can include the Jaguar® series commercially available from Solvay S.A., Hi-Care Series from Rhodia, and N-Hance and AquaCat from Ashland Inc. Jaguar® C-500 has a charge density of 0.8 meq/g and a M.Wt. of 500,000 g/mole; Jaguar Optima has a cationic charge density of about 1.25 meg/g and a M.Wt. of about 500,000 g/moles; Jaguar® C-17 has a cationic charge density of about 0.6 meq/g and a M.Wt. of about 2.2 million g/mol; Jaguar® and a cationic charge density of about 0.8 meq/g; Hi-Care 1000 has a charge density of about 0.7 meq/g and a M.Wt. of about 600,000 g/mole; N-Hance 3269 and N-Hance 3270, have a charge density of about 0.7 meq/g and a M.Wt. of about 425,000 g/mole; N-Hance 3196 has a charge density of about 0.8 meq/g and a M.Wt. of about 1,100,000 g/mole; and AquaCat CG518 has a charge density of about 0.9 meq/g and a M.Wt. of about 50,000 g/mole. N-Hance BF-13 and N-Hance BF-17 are borate (boron) free guar polymers. N-Hance BF-13 has a charge density of about 1.1 meq/g and M.W.t of about 800,000 and N-Hance BF-17 has a charge density of about 1.7 meq/g and M.W.t of about 800,000. BF-17 has a charge density of about 1.7 meq/g and M.W.t of about 800,000. BF-17 has a charge density of about 1.7 meq/g and M.W.t of about 800,000. BF-17 has a charge density of about 1.7 meq/g and M.W.t of about 800,000. BF-17 has a charge density of about 1.7 meq/g and M.W.t of about 800,000.
Cationic Non-Guar Galactomannan Polymer
The cationic polymer can be a galactomannan polymer derivative. Suitable galactomannan polymer can have a mannose to galactose ratio of greater than 2:1 on a monomer to monomer basis and can be a cationic galactomannan polymer derivative or an amphoteric galactomannan polymer derivative having a net positive charge. As used herein, the term “cationic galactomannan” refers to a galactomannan polymer to which a cationic group is added. The term “amphoteric galactomannan” refers to a galactomannan polymer to which a cationic group and an anionic group are added such that the polymer has a net positive charge.
Galactomannan polymers can be present in the endosperm of seeds of the Leguminosae family. Galactomannan polymers are made up of a combination of mannose monomers and galactose monomers. The galactomannan molecule is a straight chain mannan branched at regular intervals with single membered galactose units on specific mannose units. The mannose units are linked to each other by means of β(1-4) glycosidic linkages. The galactose branching arises by way of an α(1-6) linkage. The ratio of mannose monomers to galactose monomers varies according to the species of the plant and can be affected by climate. Non Guar Galactomannan polymer derivatives can have a ratio of mannose to galactose of greater than 2:1 on a monomer to monomer basis. Suitable ratios of mannose to galactose can also be greater than 3:1 or greater than 4:1. Analysis of mannose to galactose ratios is well known in the art and is typically based on the measurement of the galactose content.
The gum for use in preparing the non-guar galactomannan polymer derivatives can be obtained from naturally occurring materials such as seeds or beans from plants. Examples of various non-guar galactomannan polymers include Tara gum (3 parts mannose/l part galactose), Locust bean or Carob (4 parts mannose/1 part galactose), and Cassia gum (5 parts mannose/1 part galactose).
A non-guar galactomannan polymer derivative can have a M. Wt. from about 1,000 g/mol to about 10,000,000 g/mol, and a M.Wt. from about 5,000 g/mol to about 3,000,000 g/mol.
The cleansing compositions described herein can include galactomannan polymer derivatives which have a cationic charge density from about 0.5 meq/g to about 7 meq/g. The galactomannan polymer derivatives can have a cationic charge density from about 1 meq/g to about 5 meq/g. The degree of substitution of the cationic groups onto the galactomannan structure can be sufficient to provide the requisite cationic charge density.
A galactomannan polymer derivative can be a cationic derivative of the non-guar galactomannan polymer, which is obtained by reaction between the hydroxyl groups of the polygalactomannan polymer and reactive quaternary ammonium compounds. Suitable quaternary ammonium compounds for use in forming the cationic galactomannan polymer derivatives include those conforming to the general Formulas II to VI, as defined above.
Cationic non-guar galactomannan polymer derivatives formed from the reagents described above can be represented by the general Formula VII:
wherein R is the gum. The cationic galactomannan derivative can be a gum hydroxypropyltrimethylammonium chloride, which can be more specifically represented by the general Formula VIII:
The galactomannan polymer derivative can be an amphoteric galactomannan polymer derivative having a net positive charge, obtained when the cationic galactomannan polymer derivative further comprises an anionic group.
A cationic non-guar galactomannan can have a ratio of mannose to galactose which is greater than about 4:1, a M.Wt. of about 100,000 g/mol to about 500,000 g/mol, a M.Wt. of about 50,000 g/mol to about 400,000 g/mol, and a cationic charge density from about 1 meq/g to about 5 meq/g, and from about 2 meq/g to about 4 meq/g.
Cleansing compositions can include at least about 0.05% of a galactomannan polymer derivative by weight of the composition. The cleansing compositions can include from about 0.05% to about 2%, by weight of the composition, of a galactomannan polymer derivative.
Cationic Starch Polymers
Suitable cationic polymers can also be water-soluble cationically modified starch polymers. As used herein, the term “cationically modified starch” refers to a starch to which a cationic group is added prior to degradation of the starch to a smaller molecular weight, or wherein a cationic group is added after modification of the starch to achieve a desired molecular weight. The definition of the term “cationically modified starch” also includes amphoterically modified starch. The term “amphoterically modified starch” refers to a starch hydrolysate to which a cationic group and an anionic group are added.
The cleansing compositions described herein can include cationically modified starch polymers at a range of about 0.01% to about 10%, and/or from about 0.05% to about 5%, by weight of the composition.
The cationically modified starch polymers disclosed herein have a percent of bound nitrogen of from about 0.5% to about 4%.
The cationically modified starch polymers can have a molecular weight from about 850,000 g/mol to about 15,000,000 g/mol and from about 900,000 g/mol to about 5,000,000 g/mol.
Cationically modified starch polymers can have a charge density of from about 0.2 meq/g to about 5 meq/g, and from about 0.2 meq/g to about 2 meq/g. The chemical modification to obtain such a charge density can include the addition of amino and/or ammonium groups into the starch molecules. Non-limiting examples of such ammonium groups can include substituents such as hydroxypropyl trimmonium chloride, trimethylhydroxypropyl ammonium chloride, dimethylstearylhydroxypropyl ammonium chloride, and dimethyldodecylhydroxypropyl ammonium chloride. Further details are described in Solarek, D. B., Cationic Starches in Modified Starches: Properties and Uses, Wurzburg, O. B., Ed., CRC Press, Inc., Boca Raton, Fla. 1986, pp 113-125 which is hereby incorporated by reference. The cationic groups can be added to the starch prior to degradation to a smaller molecular weight or the cationic groups may be added after such modification.
A cationically modified starch polymer can have a degree of substitution of a cationic group from about 0.2 to about 2.5. As used herein, the “degree of substitution” of the cationically modified starch polymers is an average measure of the number of hydroxyl groups on each anhydroglucose unit which is derivatized by substituent groups. Since each anhydroglucose unit has three potential hydroxyl groups available for substitution, the maximum possible degree of substitution is 3. The degree of substitution is expressed as the number of moles of substituent groups per mole of anhydroglucose unit, on a molar average basis. The degree of substitution can be determined using proton nuclear magnetic resonance spectroscopy (“1H NMR”) methods well known in the art. Suitable 1H NMR techniques include those described in “Observation on NMR Spectra of Starches in Dimethyl Sulfoxide, Iodine-Complexing, and Solvating in Water-Dimethyl Sulfoxide”, Qin-Ji Peng and Arthur S. Perlin, Carbohydrate Research, 160 (1987), 57-72; and “An Approach to the Structural Analysis of Oligosaccharides by NMR Spectroscopy”, J. Howard Bradbury and J. Grant Collins, Carbohydrate Research, 71, (1979), 15-25.
The source of starch before chemical modification can be selected from a variety of sources such as tubers, legumes, cereal, and grains. For example, starch sources can include corn starch, wheat starch, rice starch, waxy corn starch, oat starch, cassaya starch, waxy barley, waxy rice starch, glutenous rice starch, sweet rice starch, amioca, potato starch, tapioca starch, oat starch, sago starch, sweet rice, or mixtures thereof. Suitable cationically modified starch polymers can be selected from degraded cationic maize starch, cationic tapioca, cationic potato starch, and mixtures thereof. Cationically modified starch polymers are cationic corn starch and cationic tapioca.
The starch, prior to degradation or after modification to a smaller molecular weight, can include one or more additional modifications. For example, these modifications may include cross-linking, stabilization reactions, phosphorylations, and hydrolyzations. Stabilization reactions can include alkylation and esterification.
Cationically modified starch polymers can be included in a cleansing composition in the form of hydrolyzed starch (e.g., acid, enzyme, or alkaline degradation), oxidized starch (e.g., peroxide, peracid, hypochlorite, alkaline, or any other oxidizing agent), physically/mechanically degraded starch (e.g., via the thermo-mechanical energy input of the processing equipment), or combinations thereof.
The starch can be readily soluble in water and can form a substantially translucent solution in water. The transparency of the composition is measured by Ultra-Violet/Visible (“UV/VIS”) spectrophotometry, which determines the absorption or transmission of UV/VIS light by a sample, using a Gretag Macbeth Colorimeter Color. A light wavelength of 600 nm has been shown to be adequate for characterizing the degree of clarity of cleansing compositions.
Cationic Copolymer of an Acrylamide Monomer and a Cationic Monomer
A cleansing composition can include a cationic copolymer of an acrylamide monomer and a cationic monomer, wherein the copolymer has a charge density of from about 1.0 meq/g to about 3.0 meq/g. The cationic copolymer can be a synthetic cationic copolymer of acrylamide monomers and cationic monomers.
Suitable cationic polymers can include:
where R9 is H or C1-4 alkyl; and R10 and R11 are independently selected from the group consisting of H, C1-4 alkyl, CH2OCH3, CH2OCH2CH(CH3)2, and phenyl, or together are C3-6cycloalkyl; and
where k=1, each of v, v′, and v″ is independently an integer of from 1 to 6, w is zero or an integer of from 1 to 10, and X− is an anion.
A cationic monomer can conform to Formula X where k=1, v=3 and w=0, z=1 and X− is Cl− to form the following structure (Formula XI):
As can be appreciated, the above structure can be referred to as diquat.
A cationic monomer can conform to Formula X wherein v and v″ are each 3, v′=1, w=1, y=1 and X− is Cl−, to form the following structure of Formula XII:
The structure of Formula XII can be referred to as triquat.
The acrylamide monomer can be either acrylamide or methacrylamide.
The cationic copolymer can be AM:TRIQUAT which is a copolymer of acrylamide and 1,3-Propanediaminium,N-[2-[[[dimethyl[3-[(2-methyl-1-oxo-2-propenyl)amino]propyl]ammonio]acetyl]amino]ethyl]2-hydroxy-N,N,N′,N′,N′-pentamethyl-, trichloride. AM:TRIQUAT is also known as polyquaternium 76 (PQ76). AM:TRIQUAT can have a charge density of 1.6 meq/g and a M.Wt. of 1.1 million g/mol.
The cationic copolymer can include an acrylamide monomer and a cationic monomer, wherein the cationic monomer is selected from the group consisting of: dimethylaminoethyl (meth)acrylate, dimethylaminopropyl (meth)acrylate, ditertiobutylaminoethyl (meth)acrylate, dimethylaminomethyl (meth)acrylamide, dimethylaminopropyl (meth)acrylamide; ethylenimine, vinylamine, 2-vinylpyridine, 4-vinylpyridine; trimethylammonium ethyl (meth)acrylate chloride, trimethylammonium ethyl (meth)acrylate methyl sulphate, dimethylammonium ethyl (meth)acrylate benzyl chloride, 4-benzoylbenzyl dimethylammonium ethyl acrylate chloride, trimethyl ammonium ethyl (meth)acrylamido chloride, trimethyl ammonium propyl (meth)acrylamido chloride, vinylbenzyl trimethyl ammonium chloride, diallyldimethyl ammonium chloride, and mixtures thereof.
The cationic copolymer can include a cationic monomer selected from the group consisting of: trimethylammonium ethyl (meth)acrylate chloride, trimethylammonium ethyl (meth)acrylate methyl sulphate, dimethylammonium ethyl (meth)acrylate benzyl chloride, 4-benzoylbenzyl dimethylammonium ethyl acrylate chloride, trimethyl ammonium ethyl (meth)acrylamido chloride, trimethyl ammonium propyl (meth)acrylamido chloride, vinylbenzyl trimethyl ammonium chloride, and mixtures thereof.
The cationic copolymer can be formed from (1) copolymers of (meth)acrylamide and cationic monomers based on (meth)acrylamide, and/or hydrolysis-stable cationic monomers, (2) terpolymers of (meth)acrylamide, monomers based on cationic (meth)acrylic acid esters, and monomers based on (meth)acrylamide, and/or hydrolysis-stable cationic monomers. Monomers based on cationic (meth)acrylic acid esters can be cationized esters of the (meth)acrylic acid containing a quaternized N atom. Cationized esters of the (meth)acrylic acid containing a quaternized N atom can be quaternized dialkylaminoalkyl (meth)acrylates with C1 to C3 in the alkyl and alkylene groups. The cationized esters of the (meth)acrylic acid containing a quaternized N atom can be selected from the group consisting of: ammonium salts of dimethylaminomethyl (meth)acrylate, dimethylaminoethyl (meth)acrylate, dimethylaminopropyl (meth)acrylate, diethylaminomethyl (meth)acrylate, diethylaminoethyl (meth)acrylate; and diethylaminopropyl (meth)acrylate quaternized with methyl chloride. The cationized esters of the (meth)acrylic acid containing a quaternized N atom can be dimethylaminoethyl acrylate, which is quaternized with an alkyl halide, or with methyl chloride or benzyl chloride or dimethyl sulfate (ADAME-Quat). The cationic monomer when based on (meth)acrylamides are quaternized dialkylaminoalkyl(meth)acrylamides with C1 to C3 in the alkyl and alkylene groups, or dimethylaminopropylacrylamide, which is quaternized with an alkyl halide, or methyl chloride or benzyl chloride or dimethyl sulfate.
The cationic monomer based on a (meth)acrylamide can be a quaternized dialkylaminoalkyl(meth)acrylamide with C1 to C3 in the alkyl and alkylene groups. The cationic monomer based on a (meth)acrylamide can be dimethylaminopropylacrylamide, which is quaternized with an alkyl halide, especially methyl chloride or benzyl chloride or dimethyl sulfate.
The cationic monomer can be a hydrolysis-stable cationic monomer. Hydrolysis-stable cationic monomers can be, in addition to a dialkylaminoalkyl(meth)acrylamide, any monomer that can be regarded as stable to the OECD hydrolysis test. The cationic monomer can be hydrolysis-stable, and the hydrolysis-stable cationic monomer can be selected from the group consisting of: diallyldimethylammonium chloride and water-soluble, cationic styrene derivatives.
The cationic copolymer can be a terpolymer of acrylamide, 2-dimethylammoniumethyl (meth)acrylate quaternized with methyl chloride (ADAME-Q) and 3-dimethylammoniumpropyl(meth)acrylamide quaternized with methyl chloride (DIMAPA-Q). The cationic copolymer can be formed from acrylamide and acrylamidopropyltrimethylammonium chloride, wherein the acrylamidopropyltrimethylammonium chloride has a charge density of from about 1.0 meq/g to about 3.0 meq/g.
The cationic copolymer can have a charge density of from about 1.1 meq/g to about 2.5 meq/g, from about 1.1 meq/g to about 2.3 meq/g, from about 1.2 meq/g to about 2.2 meq/g, from about 1.2 meq/g to about 2.1 meq/g, from about 1.3 meq/g to about 2.0 meq/g, and from about 1.3 meq/g to about 1.9 meq/g.
The cationic copolymer can have a M.Wt. from about 100 thousand g/mol to about 2 million g/mol, from about 300 thousand g/mol to about 1.8 million g/mol, from about 500 thousand g/mol to about 1.6 million g/mol, from about 700 thousand g/mol to about 1.4 million g/mol, and from about 900 thousand g/mol to about 1.2 million g/mol.
The cationic copolymer can be a trimethylammoniopropylmethacrylamide chloride-N-Acrylamide copolymer, which is also known as AM:MAPTAC. AM:MAPTAC can have a charge density of about 1.3 meq/g and a M.Wt. of about 1.1 million g/mol. The cationic copolymer can be AM:ATPAC. AM:ATPAC can have a charge density of about 1.8 meq/g and a M.Wt. of about 1.1 million g/mol.
Synthetic Polymers
A cationic polymer can be a synthetic polymer that is formed from:
The cationic polymers can be water soluble or dispersible, non-crosslinked, and synthetic cationic polymers which have the structure of Formula XIII:
Where the monomer bearing a negative charge is defined by R2′=H, C1-C4 linear or branched alkyl and R3 is:
Where the nonionic monomer is defined by R2″=H, C1-C4 linear or branched alkyl, R6=linear or branched alkyl, alkyl aryl, aryl oxy, alkyloxy, alkylaryl oxy and β is defined as
and
where G′ and G″ are, independently of one another, O, S or N—H and L=0 or 1.
Suitable monomers can include aminoalkyl (meth)acrylates, (meth)aminoalkyl (meth)acrylamides; monomers comprising at least one secondary, tertiary or quaternary amine function, or a heterocyclic group containing a nitrogen atom, vinylamine or ethylenimine; diallyldialkyl ammonium salts; their mixtures, their salts, and macromonomers deriving from therefrom.
Further examples of suitable cationic monomers can include dimethylaminoethyl (meth)acrylate, dimethylaminopropyl (meth)acrylate, ditertiobutylaminoethyl (meth)acrylate, dimethylaminomethyl (meth)acrylamide, dimethylaminopropyl (meth)acrylamide, ethylenimine, vinylamine, 2-vinylpyridine, 4-vinylpyridine, trimethylammonium ethyl (meth)acrylate chloride, trimethylammonium ethyl (meth)acrylate methyl sulphate, dimethylammonium ethyl (meth)acrylate benzyl chloride, 4-benzoylbenzyl dimethylammonium ethyl acrylate chloride, trimethyl ammonium ethyl (meth)acrylamido chloride, trimethyl ammonium propyl (meth)acrylamido chloride, vinylbenzyl trimethyl ammonium chloride, diallyldimethyl ammonium chloride.
Suitable cationic monomers can include quaternary monomers of formula —NR3+, wherein each R can be identical or different, and can be a hydrogen atom, an alkyl group comprising 1 to 10 carbon atoms, or a benzyl group, optionally carrying a hydroxyl group, and including an anion (counter-ion). Examples of suitable anions include halides such as chlorides, bromides, sulphates, hydrosulphates, alkylsulphates (for example comprising 1 to 6 carbon atoms), phosphates, citrates, formates, and acetates.
Suitable cationic monomers can also include trimethylammonium ethyl (meth)acrylate chloride, trimethylammonium ethyl (meth)acrylate methyl sulphate, dimethylammonium ethyl (meth)acrylate benzyl chloride, 4-benzoylbenzyl dimethylammonium ethyl acrylate chloride, trimethyl ammonium ethyl (meth)acrylamido chloride, trimethyl ammonium propyl (meth)acrylamido chloride, vinylbenzyl trimethyl ammonium chloride. Additional suitable cationic monomers can include trimethyl ammonium propyl (meth)acrylamido chloride.
Examples of monomers bearing a negative charge include alpha ethylenically unsaturated monomers including a phosphate or phosphonate group, alpha ethylenically unsaturated monocarboxylic acids, monoalkylesters of alpha ethylenically unsaturated dicarboxylic acids, monoalkylamides of alpha ethylenically unsaturated dicarboxylic acids, alpha ethylenically unsaturated compounds comprising a sulphonic acid group, and salts of alpha ethylenically unsaturated compounds comprising a sulphonic acid group.
Suitable monomers with a negative charge can include acrylic acid, methacrylic acid, vinyl sulphonic acid, salts of vinyl sulfonic acid, vinylbenzene sulphonic acid, salts of vinylbenzene sulphonic acid, alpha-acrylamidomethylpropanesulphonic acid, salts of alpha-acrylamidomethylpropanesulphonic acid, 2-sulphoethyl methacrylate, salts of 2-sulphoethyl methacrylate, acrylamido-2-methylpropanesulphonic acid (AMPS), salts of acrylamido-2-methylpropanesulphonic acid, and styrenesulphonate (SS).
Examples of nonionic monomers can include vinyl acetate, amides of alpha ethylenically unsaturated carboxylic acids, esters of an alpha ethylenically unsaturated monocarboxylic acids with an hydrogenated or fluorinated alcohol, polyethylene oxide (meth)acrylate (i.e. polyethoxylated (meth)acrylic acid), monoalkylesters of alpha ethylenically unsaturated dicarboxylic acids, monoalkylamides of alpha ethylenically unsaturated dicarboxylic acids, vinyl nitriles, vinylamine amides, vinyl alcohol, vinyl pyrolidone, and vinyl aromatic compounds.
Suitable nonionic monomers can also include styrene, acrylamide, methacrylamide, acrylonitrile, methylacrylate, ethylacrylate, n-propylacrylate, n-butylacrylate, methylmethacrylate, ethylmethacrylate, n-propylmethacrylate, n-butylmethacrylate, 2-ethyl-hexyl acrylate, 2-ethyl-hexyl methacrylate, 2-hydroxyethylacrylate and 2-hydroxyethylmethacrylate.
The anionic counterion (X−) in association with the synthetic cationic polymers can be any known counterion so long as the polymers remain soluble or dispersible in water, in the cleansing composition, or in a coacervate phase of the cleansing composition, and so long as the counterions are physically and chemically compatible with the essential components of the cleansing composition or do not otherwise unduly impair product performance, stability or aesthetics. Non limiting examples of suitable counterions can include halides (e.g., chlorine, fluorine, bromine, iodine), sulfate, and methylsulfate.
The cationic polymer described herein can also aid in repairing damaged hair, particularly chemically treated hair by providing a surrogate hydrophobic F-layer. The microscopically thin F-layer provides natural weatherproofing, while helping to seal in moisture and prevent further damage. Chemical treatments damage the hair cuticle and strip away its protective F-layer. As the F-layer is stripped away, the hair becomes increasingly hydrophilic. It has been found that when lyotropic liquid crystals are applied to chemically treated hair, the hair becomes more hydrophobic and more virgin-like, in both look and feel. Without being limited to any theory, it is believed that the lyotropic liquid crystal complex creates a hydrophobic layer or film, which coats the hair fibers and protects the hair, much like the natural F-layer protects the hair. The hydrophobic layer can return the hair to a generally virgin-like, healthier state. Lyotropic liquid crystals are formed by combining the synthetic cationic polymers described herein with the aforementioned anionic detersive surfactant component of the cleansing composition. The synthetic cationic polymer has a relatively high charge density. It should be noted that some synthetic polymers having a relatively high cationic charge density do not form lyotropic liquid crystals, primarily due to their abnormal linear charge densities. Such synthetic cationic polymers are described in PCT Patent App. No. WO 94/06403 which is incorporated by reference. The synthetic polymers described herein can be formulated in a stable cleansing composition that provides improved conditioning performance, with respect to damaged hair.
Cationic synthetic polymers that can form lyotropic liquid crystals have a cationic charge density of from about 2 meq/gm to about 7 meq/gm, and/or from about 3 meq/gm to about 7 meq/gm, and/or from about 4 meq/gm to about 7 meq/gm. The cationic charge density is about 6.2 meq/gm. The polymers also have a M. Wt. of from about 1,000 to about 5,000,000, and/or from about 10,000 to about 2,000,000, and/or from about 100,000 to about 2,000,000.
Cationic synthetic polymers that provide enhanced conditioning and deposition of benefit agents but do not necessarily form lytropic liquid crystals can have a cationic charge density of from about 0.7 meq/gm to about 7 meq/gm, and/or from about 0.8 meq/gm to about 5 meq/gm, and/or from about 1.0 meq/gm to about 3 meq/gm. The polymers also have a M.Wt. of from about 1,000 g/mol to about 5,000,000 g/mol, from about 10,000 g/mol to about 2,000,000 g/mol, and from about 100,000 g/mol to about 2,000,000 g/mol.
Cationic Cellulose Polymer
Suitable cationic polymers can be cellulose polymers. Suitable cellulose polymers can include salts of hydroxyethyl cellulose reacted with trimethyl ammonium substituted epoxide, referred to in the industry (CTFA) as Polyquaternium 10 and available from Dow/Amerchol Corp. (Edison, N.J., USA) in their Polymer LR, JR, and KG series of polymers. Other suitable types of cationic cellulose can include the polymeric quaternary ammonium salts of hydroxyethyl cellulose reacted with lauryl dimethyl ammonium-substituted epoxide referred to in the industry (CTFA) as Polyquaternium 24. These materials are available from Dow/Amerchol Corp. under the tradename Polymer LM-200. Other suitable types of cationic cellulose can include the polymeric quaternary ammonium salts of hydroxyethyl cellulose reacted with lauryl dimethyl ammonium-substituted epoxide and trimethyl ammonium substituted epoxide referred to in the industry (CTFA) as Polyquaternium 67. These materials are available from Dow/Amerchol Corp. under the tradename SoftCAT Polymer SL-5, SoftCAT Polymer SL-30, Polymer SL-60, Polymer SL-100, Polymer SK-L, Polymer SK-M, Polymer SK-MH, and Polymer SK-H.
Additional cationic polymers are also described in the CTFA Cosmetic Ingredient Dictionary, 3rd edition, edited by Estrin, Crosley, and Haynes, (The Cosmetic, Toiletry, and Fragrance Association, Inc., Washington, D.C. (1982)), which is incorporated herein by reference.
Techniques for analysis of formation of complex coacervates are known in the art. For example, microscopic analyses of the compositions, at any chosen stage of dilution, can be utilized to identify whether a coacervate phase has formed. Such coacervate phase can be identifiable as an additional emulsified phase in the composition. The use of dyes can aid in distinguishing the coacervate phase from other insoluble phases dispersed in the composition. Additional details about the use of cationic polymers and coacervates are disclosed in U.S. Pat. No. 9,272,164 which is incorporated by reference.
C. Liquid Carrier
As can be appreciated, cleansing compositions can desirably be in the form of pourable liquid under ambient conditions. Inclusion of an appropriate quantity of a liquid carrier can facilitate the formation of a cleansing composition having an appropriate viscosity and rheology. A cleansing composition can include, by weight of the composition, about 20% to about 95%, by weight, of a liquid carrier, and about 60% to about 85%, by weight, of a liquid carrier. The liquid carrier can be an aqueous carrier such as water.
D. Optional Components
As can be appreciated, cleansing compositions described herein can include a variety of optional components to tailor the properties and characteristics of the composition. As can be appreciated, suitable optional components are well known and can generally include any components which are physically and chemically compatible with the essential components of the cleansing compositions described herein. Optional components should not otherwise unduly impair product stability, aesthetics, or performance. Individual concentrations of optional components can generally range from about 0.001% to about 10%, by weight of a cleansing composition. Optional components can be further limited to components which will not impair the clarity of a translucent cleansing composition.
Suitable optional components which can be included in a cleansing composition can include co-surfactants, deposition aids, conditioning agents (including hydrocarbon oils, fatty esters, silicones), anti-dandruff agents, suspending agents, viscosity modifiers, dyes, nonvolatile solvents or diluents (water soluble and insoluble), pearlescent aids, foam boosters, pediculocides, pH adjusting agents, perfumes, preservatives, chelants, proteins, skin active agents, sunscreens, UV absorbers, and vitamins. The CTFA Cosmetic Ingredient Handbook, Tenth Edition (published by the Cosmetic, Toiletry, and Fragrance Association, Inc., Washington, D.C.) (2004) (hereinafter “CTFA”), describes a wide variety of non-limiting materials that can be added to the composition herein.
Conditioning Agents
A cleansing composition can include a silicone conditioning agent. Suitable silicone conditioning agents can include volatile silicone, non-volatile silicone, or combinations thereof. If including a silicone conditioning agent, the agent can be included from about 0.01% to about 10%, by weight of the composition, from about 0.1% to about 8%, from about 0.1% to about 5%, and/or from about 0.2% to about 3%. Examples of suitable silicone conditioning agents, and optional suspending agents for the silicone, are described in U.S. Reissue Pat. No. 34,584, U.S. Pat. Nos. 5,104,646, and 5,106,609, each of which is incorporated by reference herein. Suitable silicone conditioning agents can have a viscosity, as measured at 25° C., from about 20 centistokes (“csk”) to about 2,000,000 csk, from about 1,000 csk to about 1,800,000 csk, from about 50,000 csk to about 1,500,000 csk, and from about 100,000 csk to about 1,500,000 csk.
The dispersed silicone conditioning agent particles can have a volume average particle diameter ranging from about 0.01 micrometer to about 50 micrometer. For small particle application to hair, the volume average particle diameters can range from about 0.01 micrometer to about 4 micrometer, from about 0.01 micrometer to about 2 micrometer, from about 0.01 micrometer to about 0.5 micrometer. For larger particle application to hair, the volume average particle diameters typically range from about 5 micrometer to about 125 micrometer, from about 10 micrometer to about 90 micrometer, from about 15 micrometer to about 70 micrometer, and/or from about 20 micrometer to about 50 micrometer.
Additional material on silicones including sections discussing silicone fluids, gums, and resins, as well as manufacture of silicones, are found in Encyclopedia of Polymer Science and Engineering, vol. 15, 2d ed., pp 204-308, John Wiley & Sons, Inc. (1989), which is incorporated herein by reference.
Silicone emulsions suitable for the cleansing compositions described herein can include emulsions of insoluble polysiloxanes prepared in accordance with the descriptions provided in U.S. Pat. No. 4,476,282 and U.S. Patent Application Publication No. 2007/0276087 each of which is incorporated herein by reference. Suitable insoluble polysiloxanes include polysiloxanes such as alpha, omega hydroxy-terminated polysiloxanes or alpha, omega alkoxy-terminated polysiloxanes having a molecular weight within the range from about 50,000 to about 500,000 g/mol. The insoluble polysiloxane can have an average molecular weight within the range from about 50,000 to about 500,000 g/mol. For example, the insoluble polysiloxane may have an average molecular weight within the range from about 60,000 to about 400,000; from about 75,000 to about 300,000; from about 100,000 to about 200,000; or the average molecular weight may be about 150,000 g/mol. The insoluble polysiloxane can have an average particle size within the range from about 30 nm to about 10 micron. The average particle size may be within the range from about 40 nm to about 5 micron, from about 50 nm to about 1 micron, from about 75 nm to about 500 nm, or about 100 nm, for example.
Other classes of silicones suitable for the cleansing compositions described herein can include i) silicone fluids, including silicone oils, which are flowable materials having viscosity less than about 1,000,000 csk as measured at 25° C.; ii) aminosilicones, which contain at least one primary, secondary or tertiary amine; iii) cationic silicones, which contain at least one quaternary ammonium functional group; iv) silicone gums; which include materials having viscosity greater or equal to 1,000,000 csk as measured at 25° C.; v) silicone resins, which include highly cross-linked polymeric siloxane systems; vi) high refractive index silicones, having refractive index of at least 1.46, and vii) mixtures thereof.
Alternatively, the cleansing composition can be substantially free of silicones. As used herein, substantially free of silicones means from about 0 to about 0.2 wt. %.
Organic Conditioning Materials
The conditioning agent of the cleansing compositions described herein can also include at least one organic conditioning material such as oil or wax, either alone or in combination with other conditioning agents, such as the silicones described above. The organic material can be non-polymeric, oligomeric or polymeric. The organic material can be in the form of an oil or wax and can be added in the cleansing formulation neat or in a pre-emulsified form. Suitable examples of organic conditioning materials can include: i) hydrocarbon oils; ii) polyolefins, iii) fatty esters, iv) fluorinated conditioning compounds, v) fatty alcohols, vi) alkyl glucosides and alkyl glucoside derivatives; vii) quaternary ammonium compounds; viii) polyethylene glycols and polypropylene glycols having a molecular weight of up to about 2,000,000 including those with CTFA names PEG-200, PEG-400, PEG-600, PEG-1000, PEG-2M, PEG-7M, PEG-14M, PEG-45M and mixtures thereof.
Emulsifiers
A variety of anionic and nonionic emulsifiers can be used in the cleansing composition of the present invention. The anionic and nonionic emulsifiers can be either monomeric or polymeric in nature. Monomeric examples include, by way of illustrating and not limitation, alkyl ethoxylates, alkyl sulfates, soaps, and fatty esters and their derivatives. Polymeric examples include, by way of illustrating and not limitation, polyacrylates, polyethylene glycols, and block copolymers and their derivatives. Naturally occurring emulsifiers such as lanolins, lecithin and lignin and their derivatives are also non-limiting examples of useful emulsifiers.
Chelating Agents
The cleansing composition can also comprise a chelant. Suitable chelants include those listed in A E Martell & R M Smith, Critical Stability Constants, Vol. 1, Plenum Press, New York & London (1974) and A E Martell & R D Hancock, Metal Complexes in Aqueous Solution, Plenum Press, New York & London (1996) both incorporated herein by reference. When related to chelants, the term “salts and derivatives thereof” means the salts and derivatives comprising the same functional structure (e.g., same chemical backbone) as the chelant they are referring to and that have similar or better chelating properties. This term includes alkali metal, alkaline earth, ammonium, substituted ammonium (i.e. monoethanolammonium, diethanolammonium, triethanolammonium) salts, esters of chelants having an acidic moiety and mixtures thereof, in particular all sodium, potassium or ammonium salts. The term “derivatives” also includes “chelating surfactant” compounds, such as those exemplified in U.S. Pat. No. 5,284,972, and large molecules comprising one or more chelating groups having the same functional structure as the parent chelants, such as polymeric EDDS (ethylenediaminedisuccinic acid) disclosed in U.S. Pat. No. 5,747,440. U.S. Pat. Nos. 5,284,972 and 5,747,440 are each incorporated by reference herein. Suitable chelants can further include histidine.
Levels of an EDDS chelant or histidine chelant in the cleansing compositions can be low. For example, an EDDS chelant or histidine chelant can be included at about 0.01%, by weight. Above about 10% by weight, formulation and/or human safety concerns can arise. The level of an EDDS chelant or histidine chelant can be at least about 0.01%, by weight, at least about 0.05%, by weight, at least about 0.1%, by weight, at least about 0.25%, by weight, at least about 0.5%, by weight, at least about 1%, by weight, or at least about 2%, by weight, by weight of the cleansing composition.
Gel Network
A cleansing composition can also include a fatty alcohol gel network. Gel networks are formed by combining fatty alcohols and surfactants in the ratio of from about 1:1 to about 40:1, from about 2:1 to about 20:1, and/or from about 3:1 to about 10:1. The formation of a gel network involves heating a dispersion of the fatty alcohol in water with the surfactant to a temperature above the melting point of the fatty alcohol. During the mixing process, the fatty alcohol melts, allowing the surfactant to partition into the fatty alcohol droplets. The surfactant brings water along with it into the fatty alcohol. This changes the isotropic fatty alcohol drops into liquid crystalline phase drops. When the mixture is cooled below the chain melt temperature, the liquid crystal phase is converted into a solid crystalline gel network. Gel networks can provide a number of benefits to cleansing compositions. For example, a gel network can provide a stabilizing benefit to cosmetic creams and hair conditioners. In addition, gel networks can provide conditioned feel benefits to hair conditioners and shampoos.
A fatty alcohol can be included in the gel network at a level by weight of from about 0.05%, by weight, to about 14%, by weight. For example, the fatty alcohol can be included in an amount ranging from about 1%, by weight, to about 10%, by weight, and/or from about 6%, by weight, to about 8%, by weight.
Suitable fatty alcohols include those having from about 10 to about 40 carbon atoms, from about 12 to about 22 carbon atoms, from about 16 to about 22 carbon atoms, and/or about 16 to about 18 carbon atoms. These fatty alcohols can be straight or branched chain alcohols and can be saturated or unsaturated. Nonlimiting examples of fatty alcohols include cetyl alcohol, stearyl alcohol, behenyl alcohol, and mixtures thereof. Mixtures of cetyl and stearyl alcohol in a ratio of from about 20:80 to about 80:20 are suitable.
A gel network can be prepared by charging a vessel with water. The water can then be heated to about 74° C. Cetyl alcohol, stearyl alcohol, and surfactant can then be added to the heated water. After incorporation, the resulting mixture can passed through a heat exchanger where the mixture is cooled to about 35° C. Upon cooling, the fatty alcohols and surfactant crystallized can form crystalline gel network. Table 1 provides the components and their respective amounts for an example gel network composition.
To prepare the gel network pre-mix of Table 1, water is heated to about 74° C. and the fatty alcohol and gel network surfactant are added to it in the quantities depicted in Table 1. After incorporation, this mixture is passed through a mill and heat exchanger where it is cooled to about 32° C. As a result of this cooling step, the fatty alcohol, the gel network surfactant, and the water form a crystalline gel network.
1For anionic gel networks, suitable gel network surfactants above include surfactants with a net negative charge including sulfonates, carboxylates and phosphates among others and mixtures thereof.
For cationic gel networks, suitable gel network surfactants above include surfactants with a net positive charge including quaternary ammonium surfactants and mixtures thereof. For Amphoteric or Zwitterionic gel networks, suitable gel network surfactants above include surfactants with both a positive and negative charge at product usage pH including betaines, amine oxides, sultaines, amino acids among others and mixtures thereof.
Benefit Agents
A cleansing composition can further include one or more benefit agents. Exemplary benefit agents include, but are not limited to, particles, colorants, perfume microcapsules, gel networks, and other insoluble skin or hair conditioning agents such as skin silicones, natural oils such as sun flower oil or castor oil. The benefit agent can be selected from the group consisting of: particles; colorants; perfume microcapsules; gel networks; other insoluble skin or hair conditioning agents such as skin silicones, natural oils such as sun flower oil or castor oil; and mixtures thereof.
Suspending Agent
A cleansing composition can include a suspending agent at concentrations effective for suspending water-insoluble material in dispersed form in the compositions or for modifying the viscosity of the composition. Such concentrations range from about 0.1% to about 10%, and from about 0.3% to about 5.0%, by weight of the compositions. As can be appreciated however, suspending agents may not be necessary when certain glyceride ester crystals are included as certain glyceride ester crystals can act as suitable suspending or structuring agents.
Suitable suspending agents can include anionic polymers and nonionic polymers. Useful herein are vinyl polymers such as cross linked acrylic acid polymers with the CTFA name Carbomer, cellulose derivatives and modified cellulose polymers such as methyl cellulose, ethyl cellulose, hydroxyethyl cellulose, hydroxypropyl methyl cellulose, nitro cellulose, sodium cellulose sulfate, sodium carboxymethyl cellulose, crystalline cellulose, cellulose powder, polyvinylpyrrolidone, polyvinyl alcohol, guar gum, hydroxypropyl guar gum, xanthan gum, arabia gum, tragacanth, galactan, carob gum, guar gum, karaya gum, carrageenin, pectin, agar, quince seed (Cydonia oblonga Mill), starch (rice, corn, potato, wheat), algae colloids (algae extract), microbiological polymers such as dextran, succinoglucan, pulleran, starch-based polymers such as carboxymethyl starch, methylhydroxypropyl starch, alginic acid-based polymers such as sodium alginate, alginic acid propylene glycol esters, acrylate polymers such as sodium polyacrylate, polyethylacrylate, polyacrylamide, polyethyleneimine, and inorganic water soluble material such as bentonite, aluminum magnesium silicate, laponite, hectonite, and anhydrous silicic acid.
Other suitable suspending agents can include crystalline suspending agents which can be categorized as acyl derivatives, long chain amine oxides, and mixtures thereof. Examples of such suspending agents are described in U.S. Pat. No. 4,741,855, which is incorporated herein by reference. Suitable suspending agents include ethylene glycol esters of fatty acids having from 16 to 22 carbon atoms. The suspending agent can be an ethylene glycol stearates, both mono and distearate, but particularly the distearate containing less than about 7% of the mono stearate. Other suitable suspending agents include alkanol amides of fatty acids, having from about 16 to about 22 carbon atoms, alternatively from about 16 to about 18 carbon atoms, suitable examples of which include stearic monoethanolamide, stearic diethanolamide, stearic monoisopropanolamide and stearic monoethanolamide stearate. Other long chain acyl derivatives include long chain esters of long chain fatty acids (e.g., stearyl stearate, cetyl palmitate, etc.); long chain esters of long chain alkanol amides (e.g., stearamide diethanolamide distearate, stearamide monoethanolamide stearate); and glyceryl esters as previously described. Long chain acyl derivatives, ethylene glycol esters of long chain carboxylic acids, long chain amine oxides, and alkanol amides of long chain carboxylic acids can also be used as suspending agents.
Other long chain acyl derivatives suitable for use as suspending agents include N,N-dihydrocarbyl amido benzoic acid and soluble salts thereof (e.g., Na, K), particularly N,N-di(hydrogenated) C16, C18 and tallow amido benzoic acid species of this family, which are commercially available from Stepan Company (Northfield, Ill., USA).
Examples of suitable long chain amine oxides for use as suspending agents include alkyl dimethyl amine oxides, e.g., stearyl dimethyl amine oxide.
Other suitable suspending agents include primary amines having a fatty alkyl moiety having at least about 16 carbon atoms, examples of which include palmitamine or stearamine, and secondary amines having two fatty alkyl moieties each having at least about 12 carbon atoms, examples of which include dipalmitoylamine or di(hydrogenated tallow)amine. Still other suitable suspending agents include di(hydrogenated tallow)phthalic acid amide, and crosslinked maleic anhydride-methyl vinyl ether copolymer.
Viscosity Modifiers
Viscosity modifiers can be used to modify the rheology of a cleansing composition. Suitable viscosity modifiers can include Carbomers with tradenames Carbopol 934, Carbopol 940, Carbopol 950, Carbopol 980, and Carbopol 981, all available from B. F. Goodrich Company, acrylates/steareth-20 methacrylate copolymer with tradename ACRYSOL 22 available from Rohm and Hass, nonoxynyl hydroxyethylcellulose with tradename AMERCELL POLYMER HM-1500 available from Amerchol, methylcellulose with tradename BENECEL, hydroxyethyl cellulose with tradename NATROSOL, hydroxypropyl cellulose with tradename KLUCEL, cetyl hydroxyethyl cellulose with tradename POLYSURF 67, all supplied by Hercules, ethylene oxide and/or propylene oxide based polymers with tradenames CARBOWAX PEGs, POLYOX WASRs, and UCON FLUIDS, all supplied by Amerchol. Sodium chloride can also be used as a viscosity modifier. Other suitable rheology modifiers can include cross-linked acrylates, cross-linked maleic anhydride co-methylvinylethers, hydrophobically modified associative polymers, and mixtures thereof.
The cleansing composition can have a viscosity of about 1 cP to about 20,000 cP, or from about 100 cps to about 15,000 cps, or from 2,500 cP to about 12,000 cP, or from 1 cP to about 5000 cP, or from about 3,500 cP to about 8,500 cP, measured at 26.6° C. with a Brookfield R/S Plus Rheometer at 2 s−1. cP means centipoises.
Dispersed Particles
Dispersed particles as known in the art can be included in a cleansing composition. If including such dispersed particles, the particles can be incorporated, by weight of the composition, at levels of about 0.025% or more, about 0.05% or more, about 0.1% or more, about 0.25% or more, and about 0.5% or more. However, the cleansing compositions can also contain, by weight of the composition, about 20% or fewer dispersed particles, about 10% or fewer dispersed particles, about 5% or fewer dispersed particles, about 3% or fewer dispersed particles, and about 2% or fewer dispersed particles.
As can be appreciated, a cleansing composition can include still further optional components. For example, amino acids can be included. Suitable amino acids can include water soluble vitamins such as vitamins B1, B2, B6, B12, C, pantothenic acid, pantothenyl ethyl ether, panthenol, biotin, and their derivatives, water soluble amino acids such as asparagine, alanin, indole, glutamic acid and their salts, water insoluble vitamins such as vitamin A, D, E, and their derivatives, water insoluble amino acids such as tyrosine, tryptamine, and their salts.
Anti-dandruff agents can be included. As can be appreciated, the formation of a coacervate can facilitate deposition of the anti-dandruff agent to the scalp.
A cleansing composition can optionally include pigment materials such as inorganic, nitroso, monoazo, disazo, carotenoid, triphenyl methane, triaryl methane, xanthene, quinoline, oxazine, azine, anthraquinone, indigoid, thionindigoid, quinacridone, phthalocianine, botanical, natural colors, including: water soluble components such as those having C. 1. Names. The compositions can also include antimicrobial agents which are useful as cosmetic biocides and antidandruff agents including: water soluble components such as piroctone olamine, water insoluble components such as 3,4,4′-trichlorocarbanilide (trichlosan), triclocarban and zinc pyrithione.
One or more stabilizers can be included. For example, one or more of ethylene glycol distearate, citric, citrate, a preservative such as kathon, sodium benzoate, sodium salicylate and ethylenediaminetetraacetic acid (“EDTA”) can be included to improve the lifespan of a cleansing composition.
Foam Dispenser
The shampoo composition can be stored and dispensed from an aerosol foam dispenser that can include a reservoir for holding the shampoo composition. The reservoir may be made from any suitable material including materials selected from the group consisting of plastic, metal, alloy, laminate, and combinations thereof. The reservoir may be for one-time use. The reservoir may be removable from the aerosol foam dispenser. Alternatively, the reservoir may be integrated with the aerosol foam dispenser. Alternatively, there may be two or more reservoirs.
The reservoir may be comprised of a material selected from the group consisting of rigid materials, flexible materials, and combinations thereof. The reservoir may be comprised of a rigid material if it does not collapse under external atmospheric pressure when it is subject to an interior partial vacuum.
Alternatively, the hair composition can be stored and dispensed from a mechanical foam dispenser. Non-limiting examples of suitable pump dispensers include those described in WO 2004/078903, WO 2004/078901, and WO 2005/078063 and may be supplied by Albea (60 Electric Ave., Thomaston, CT 06787 USA) or Rieke Packaging Systems (500 West Seventh St., Auburn, Indianna 46706).
The shampoo composition can be stored and dispensed from a squeeze foam dispenser. An example of squeeze foamer is EZ'R available from Albéa.
The shampoo composition and/or the dispenser can be free or substantially free of a propellant, for instance aerosol propellants.
Propellant
The shampoo composition described herein may comprise from about from about 2% to about 10% propellant, alternatively from about 3% to about 8% propellant, and alternatively from about 4% to about 7% propellant, by weight of the shampoo.
The propellant may comprise one or more volatile materials, which in a gaseous state, may carry the other components of the shampoo in particulate or droplet form. The propellant may have a boiling point within the range of from about −45° C. to about 5° C. The propellant may be liquefied when packaged in convention aerosol containers under pressure. The rapid boiling of the propellant upon leaving the aerosol foam dispenser may aid in the atomization of the other components of the shampoo composition.
Aerosol propellants which may be employed in the aerosol composition may include the chemically-inert hydrocarbons such as propane, n-butane, isobutane, cyclopropane, and mixtures thereof, as well as halogenated hydrocarbons such as dichlorodifluoromethane, 1,1-dichloro-1,1,2,2-tetrafluoroethane, 1-chloro-1,1-difluoro-2,2-trifluoroethane, 1-chloro-1,1-difluoroethylene, 1,1-difluoroethane, dimethyl ether, monochlorodifluoromethane, trans-1,3,3,3-tetrafluoropropene (HFO 1234ze available by Honeywell), and mixtures thereof. The propellant may comprise hydrocarbons such as isobutane, propane, and butane—these materials may be used for their low ozone reactivity and may be used as individual components where their vapor pressures at 21.1° C. range from about 1.17 Bar to about 7.45 Bar, alternatively from about 1.17 Bar to about 4.83 Bar, and alternatively from about 2.14 Bar to about 3.79 Bar. The propellant may comprise hydrofluoroolefins (HFOs).
Compositions that use an HFO propellant can have a higher foam densities (approximately 2× greater) versus hydrocarbon propellants and at equal formula pressure and formula % saturated pressure. The higher density can enable higher gravimetric foam dosage per unit volume of the resulting dispensed foam shampoo. This means that a consumer could use a smaller volume of foam to achieve similar results when using a less dense foam.
The pressure and % saturated pressure can be important to enable sufficient foam dispensing over the life of the product (from beginning to middle to end of the pressurized container). The 1,3,3,3-tetrafluoropropene can also enable significantly greater gloss or shine of the dispensed foam.
Method of Making a Cleansing Composition
A cleansing composition described herein can be formed similarly to known cleansing compositions. For example, the process of making a cleansing composition can include the step of mixing the surfactant, cationic polymer, and liquid carrier together to form a cleansing composition.
A. Clarity Assessment
Measurement of % Transmittance (% T)
Techniques for analysis of formation of complex coacervates are known in the art. One method to assess coacervate formation upon dilution for a transparent or translucent composition is to use a spectrophotometer to measure the percentage of light transmitted through the diluted sample (% T). As percent light transmittance (% T) values measured of the dilution decrease, typically higher levels of coacervate are formed. Dilutions samples at various weight ratios of water to composition can be prepared, for example 2 parts of water to 1 part composition (2:1), or 7.5 parts of water to 1 part composition (7.5:1), or 16 parts of water to 1 part composition (16:1), or 34 parts of water to 1 part composition (34:1), and the % T measured for each dilution ratio sample. Examples of possible dilution ratios may include 2:1, 3:1, 5:1, 7.5:1, 11:1, 16:1, 24:1, or 34:1. By averaging the % T values for samples that span a range of dilution ratios, it is possible to simulate and ascertain how much coacervate a composition on average would form as a consumer applies the composition to wet hair, lathers, and then rinses it out. Average % T can be calculated by taking the numerical average of individual % T measurements for the following dilution ratios: 2:1, 3:1, 5:1, 7.5:1, 11:1, 16:1, 24:1, and 34:1.
% T can be measured using Ultra-Violet/Visible (UV/VI) spectrophotometry which determines the transmission of UV/VIS light through a sample. A light wavelength of 600 nm has been shown to be adequate for characterizing the degree of light transmittance through a sample. Typically, it is best to follow the specific instructions relating to the specific spectrophotometer being used. In general, the procedure for measuring percent transmittance starts by setting the spectrophotometer to 600 nm. Then a calibration “blank” is run to calibrate the readout to 100 percent transmittance. A single test sample is then placed in a cuvette designed to fit the specific spectrophotometer and care is taken to insure no air bubbles are within the sample before the % T is measured by the spectrophotometer at 600 nm. Alternatively, multiple samples can be measured simultaneously by using a spectrophotometer such as the SpectraMax M-5 available from Molecular Devices. Multiple dilution samples can be prepared within a 96 well plate (VWR catalog #82006-448) and then transferred to a 96 well visible flat bottom plate (Greiner part #655-001), ensuring that no air bubbles are within the sample. The flat bottom plate is placed within the SpectraMax M-5 and % T measured using the Software Pro v.5™ software available from Molecular Devices.
B. Lasentec FBRM Method
The composition does not contain coacervate prior to dilution. One option to measure lack of coacervate is using Lasentec FBRM Method with no dilution. A Lasentec Focused Beam Reflectance Method (FBRM) [model S400A available from Mettler Toledo Corp] may be used to determine floe size and amount as measured by chord length and particle counts/sec (counts per sec). The composition containing only surfactants substantially free from sulfates, optionally amphoteric surfactants, cationic deposition polymers and a low level of inorganic salt does not contain flocs. The composition with other materials added does not contain flocs of different particle size than the particle size of the other materials added.
C. Coacervate Quantity
Coacervate Centrifuge Method
Presence of coacervate can be measured by centrifuging a cleansing composition and measuring coacervate gravimetrically. The cleansing composition containing only surfactants substantially free from sulfates, amphoteric surfactants, cationic deposition polymers and a low level of inorganic salt is centrifuged for 20 minutes at 9200 rpm using a Beckman Couller TJ25 centrifuge. Several time/rpm combinations can be used. The supernatant is then removed and the remaining settled coacervate assessed gravimetrically. % Coacervate is calculated as the weight of settled coacervate as a percentage of the weight of cleansing composition added to the centrifuge tube using the equation below. This quantifies the percentage of the cleansing composition the participates in the coacervate phase. The % coacervate for composition containing surfactants substantially free from sulfates, optionally amphoteric surfactants, cationic deposition polymers and a low level of inorganic salt is 0%.
D. Lather Characterization
Kruss DFA100 Lather Characterization
A cleansing composition dilution of 10 parts by weight water to 1 part by weight cleansing is prepared. The shampoo dilution is dispensed into the Kruss DFA100 which generates the lather and measures lather properties.
E. Wet Combing Characterization
Wet Combing Force Method
Hair switches of 4 grams general population hair at 8 inches length are used for the measurement. Each hair switch is treated with 4 cycles (1 lather/rinse steps per cycle, 0.1 gm cleansing composition/gm hair on each lather/rinse step, drying between each cycle) with the cleansing composition. Four switches are treated with each shampoo. The hair is not dried after the last treatment cycle. While the hair is wet, the hair is pulled through the fine tooth half of two Beautician 3000 combs. Force to pull the hair switch through the combs is measured by a friction analyzer (such as Instron or MTS tensile measurement) with a load cell and outputted in gram-force (gf). The pull is repeated for a total of five pulls per switch. Average wet combing force is calculated by averaging the force measurement from the five pulls across the four hair switches treated with each cleansing composition. Data can be shown as average wet combing force through one or both of the two combs.
The following Examples illustrate various personal care compositions. Each personal care composition is prepared by conventional formulation and mixing techniques.
It will be appreciated that other modifications of the present disclosure are within the skill of those in the hair care formulation art can be undertaken without departing from the spirit and scope of this invention. All parts, percentages, and ratios herein are by weight unless otherwise specified. Some components may come from suppliers as dilute solutions. The levels given reflect the weight percent of the active material, unless otherwise specified. A level of perfume and/or preservatives may also be included in the following examples.
The dimensions and values disclosed herein are not to be understood as being strictly limited to the exact numerical values recited. Instead, unless otherwise specified, each such dimension is intended to mean both the recited value and a functionally equivalent range surrounding that value. For example, a dimension disclosed as “40 mm” is intended to mean “about 40 mm.”
Every document cited herein, including any cross referenced or related patent or application, is hereby incorporated herein by reference in its entirety unless expressly excluded or otherwise limited. The citation of any document is not an admission that it is prior art with respect to any invention disclosed or claimed herein or that it alone, or in any combination with any other reference or references, teaches, suggests, or discloses any such invention. Further, to the extent that any meaning or definition of a term in this document conflicts with any meaning or definition of the same term in a document incorporated by reference, the meaning or definition assigned to that term in this document shall govern.
While particular embodiments of the present invention have been illustrated and described, it would be obvious to those skilled in the art that various other changes and modifications can be made without departing from the spirit and scope of the invention. It is therefore intended to cover in the appended claims all such changes and modifications that are within the scope of this invention.
| Number | Name | Date | Kind |
|---|---|---|---|
| 1489388 | Glenn | Apr 1924 | A |
| 1600340 | Hoffman | Sep 1926 | A |
| 1612255 | William | Dec 1926 | A |
| 2438091 | Lynch | Mar 1948 | A |
| 2528378 | Mannheimer | Oct 1950 | A |
| 2658072 | Milton | Nov 1953 | A |
| 2809971 | Jack et al. | Oct 1957 | A |
| 2879231 | Marshall | Mar 1959 | A |
| 3219656 | Boettner | Nov 1965 | A |
| 3236733 | Karsten et al. | Feb 1966 | A |
| 3373208 | Blumenthal | Mar 1968 | A |
| 3636113 | Hall | Jan 1972 | A |
| 3709437 | Wright | Jan 1973 | A |
| 3716498 | Hall | Feb 1973 | A |
| 3753196 | Kurtz et al. | Aug 1973 | A |
| 3761418 | Parran | Sep 1973 | A |
| 3792068 | Luedders et al. | Feb 1974 | A |
| 3887692 | Gilman | Jun 1975 | A |
| 3904741 | Jones et al. | Sep 1975 | A |
| 3950532 | Bouillon et al. | Apr 1976 | A |
| 3959160 | Horsler et al. | May 1976 | A |
| 4049792 | Elsnau | Sep 1977 | A |
| 4089945 | Brinkman et al. | May 1978 | A |
| 4120948 | Shelton | Oct 1978 | A |
| 4137180 | Naik | Jan 1979 | A |
| 4237155 | Kardouche | Dec 1980 | A |
| 4309119 | Wittersheim | Jan 1982 | A |
| 4323683 | Bolich, Jr. et al. | Apr 1982 | A |
| 4329334 | Su et al. | May 1982 | A |
| 4345080 | Bolich, Jr. | Aug 1982 | A |
| 4359456 | Gosling et al. | Nov 1982 | A |
| 4379753 | Bolich, Jr. | Apr 1983 | A |
| 4430243 | Bragg | Feb 1984 | A |
| 4470982 | Winkler | Sep 1984 | A |
| 4726945 | Patel | Feb 1988 | A |
| 4732696 | Urfer | Mar 1988 | A |
| 4839166 | Grollier et al. | Jun 1989 | A |
| 4854333 | Inman et al. | Aug 1989 | A |
| 4867971 | Ryan et al. | Sep 1989 | A |
| 4931274 | Barabino et al. | Jun 1990 | A |
| 4973416 | Kennedy | Nov 1990 | A |
| 4985238 | Tanner et al. | Jan 1991 | A |
| 4997641 | Hartnett | Mar 1991 | A |
| 5019375 | Tanner et al. | May 1991 | A |
| 5093112 | Birtwistle et al. | Mar 1992 | A |
| 5104646 | Bolich, Jr. | Apr 1992 | A |
| 5106609 | Bolich, Jr. | Apr 1992 | A |
| 5135747 | Faryniarz et al. | Aug 1992 | A |
| 5156834 | Beckmeyer et al. | Oct 1992 | A |
| 5294644 | Login et al. | Mar 1994 | A |
| 5296157 | Macgilp et al. | Mar 1994 | A |
| 5296622 | Uphues | Mar 1994 | A |
| 5298640 | Callaghan et al. | Mar 1994 | A |
| 5332569 | Wood et al. | Jul 1994 | A |
| 5364031 | Taniguchi et al. | Nov 1994 | A |
| 5374421 | Tashiro | Dec 1994 | A |
| 5374614 | Behan et al. | Dec 1994 | A |
| 5409695 | Abrutyn et al. | Apr 1995 | A |
| 5415810 | Lee et al. | May 1995 | A |
| 5417965 | Janchitraponvej et al. | May 1995 | A |
| 5429816 | Hofrichter et al. | Jul 1995 | A |
| 5439682 | Wivell | Aug 1995 | A |
| 5441659 | Minor | Aug 1995 | A |
| 5486303 | Capeci | Jan 1996 | A |
| 5489392 | Capeci | Feb 1996 | A |
| 5496488 | Kacher et al. | Mar 1996 | A |
| 5516448 | Capeci | May 1996 | A |
| 5536493 | Dubief | Jul 1996 | A |
| 5554588 | Behan et al. | Sep 1996 | A |
| 5560918 | Wivell | Oct 1996 | A |
| 5565422 | Del | Oct 1996 | A |
| 5569645 | Dinniwell | Oct 1996 | A |
| 5574005 | Welch | Nov 1996 | A |
| 5576282 | Miracle | Nov 1996 | A |
| 5578298 | Berthiaume | Nov 1996 | A |
| 5595967 | Miracle | Jan 1997 | A |
| 5597936 | Perkins | Jan 1997 | A |
| 5599549 | Wivell | Feb 1997 | A |
| 5624666 | Coffindaffer et al. | Apr 1997 | A |
| 5635469 | Fowler et al. | Jun 1997 | A |
| 5665267 | Dowell et al. | Sep 1997 | A |
| 5691297 | Nassano | Nov 1997 | A |
| 5714137 | Trinh | Feb 1998 | A |
| 5747436 | Patel | May 1998 | A |
| 5776444 | Birtwistle et al. | Jul 1998 | A |
| 5800897 | Sharma | Sep 1998 | A |
| 5816446 | Steindorf et al. | Oct 1998 | A |
| 5830440 | Sturla et al. | Nov 1998 | A |
| 5853618 | Barker | Dec 1998 | A |
| 5879584 | Bianchetti | Mar 1999 | A |
| 5891424 | Bretzler et al. | Apr 1999 | A |
| 5902225 | Monson | May 1999 | A |
| 5925603 | D Angelo | Jul 1999 | A |
| 5942217 | Woo et al. | Aug 1999 | A |
| 5976514 | Guskey et al. | Nov 1999 | A |
| 5980877 | Baravetto | Nov 1999 | A |
| 5985939 | Minor | Nov 1999 | A |
| 6015547 | Yam | Jan 2000 | A |
| 6015780 | Llosas Bigorra et al. | Jan 2000 | A |
| 6020303 | Cripe et al. | Feb 2000 | A |
| 6039933 | Samain et al. | Mar 2000 | A |
| 6046152 | Vinson et al. | Apr 2000 | A |
| 6060443 | Cripe et al. | May 2000 | A |
| 6087309 | Vinson et al. | Jul 2000 | A |
| 6110451 | Matz et al. | Aug 2000 | A |
| 6133222 | Vinson et al. | Oct 2000 | A |
| 6139828 | Mccullough | Oct 2000 | A |
| 6153567 | Hughes | Nov 2000 | A |
| 6153569 | Halloran | Nov 2000 | A |
| 6162834 | Sebillotte-Arnaud et al. | Dec 2000 | A |
| 6180121 | Guenin et al. | Jan 2001 | B1 |
| 6225464 | Hiler, II | May 2001 | B1 |
| 6231844 | Nambu | May 2001 | B1 |
| 6232302 | Alberico et al. | May 2001 | B1 |
| 6248135 | Trinh et al. | Jun 2001 | B1 |
| 6268431 | Snyder et al. | Jul 2001 | B1 |
| 6284225 | Bhatt | Sep 2001 | B1 |
| 6329331 | Aronson | Dec 2001 | B1 |
| 6335312 | Coffindaffer et al. | Jan 2002 | B1 |
| 6352688 | Scavone et al. | Mar 2002 | B1 |
| 6386392 | Argentieri | May 2002 | B1 |
| 6413920 | Bettiol | Jul 2002 | B1 |
| 6423305 | Cauwet-Martin et al. | Jul 2002 | B1 |
| 6426326 | Mitra et al. | Jul 2002 | B1 |
| 6436442 | Woo et al. | Aug 2002 | B1 |
| 6451300 | Dunlop et al. | Sep 2002 | B1 |
| 6488943 | Beerse et al. | Dec 2002 | B1 |
| 6511669 | Garnier et al. | Jan 2003 | B1 |
| 6565863 | Guillou et al. | May 2003 | B1 |
| 6579907 | Sebillotte-Arnaud et al. | Jun 2003 | B1 |
| 6627585 | Steer | Sep 2003 | B1 |
| 6642194 | Harrison | Nov 2003 | B2 |
| 6649155 | Dunlop et al. | Nov 2003 | B1 |
| 6656923 | Trinh | Dec 2003 | B1 |
| 6660288 | Behan et al. | Dec 2003 | B1 |
| 6679324 | Den et al. | Jan 2004 | B2 |
| 6716455 | Birkel | Apr 2004 | B2 |
| 6716805 | Sherry | Apr 2004 | B1 |
| 6740713 | Busch et al. | May 2004 | B1 |
| 6743760 | Hardy et al. | Jun 2004 | B1 |
| 6764986 | Busch et al. | Jul 2004 | B1 |
| 6767507 | Woo et al. | Jul 2004 | B1 |
| 6794356 | Turner | Sep 2004 | B2 |
| 6814088 | Barnabas et al. | Nov 2004 | B2 |
| 6827795 | Kasturi et al. | Dec 2004 | B1 |
| 6869923 | Cunningham | Mar 2005 | B1 |
| 6897253 | Schmucker-castner | May 2005 | B2 |
| 6908889 | Niemiec et al. | Jun 2005 | B2 |
| 6930078 | Wells | Aug 2005 | B2 |
| 6992054 | Lee et al. | Jan 2006 | B2 |
| 7018978 | Miracle et al. | Mar 2006 | B2 |
| 7030068 | Clare et al. | Apr 2006 | B2 |
| 7100767 | Chomik et al. | Sep 2006 | B2 |
| 7151079 | Fack et al. | Dec 2006 | B2 |
| 7172099 | Hoefte | Feb 2007 | B2 |
| 7202198 | Gordon et al. | Apr 2007 | B2 |
| 7217752 | Noveon | May 2007 | B2 |
| 7220408 | Decoster et al. | May 2007 | B2 |
| 7223361 | Kvietok | May 2007 | B2 |
| 7223385 | Gawtrey et al. | May 2007 | B2 |
| 7485289 | Gawtrey et al. | Feb 2009 | B2 |
| 7504094 | Decoster et al. | Mar 2009 | B2 |
| 7531497 | Midha et al. | May 2009 | B2 |
| 7541320 | Dabkowski et al. | Jun 2009 | B2 |
| 7598213 | Geary et al. | Oct 2009 | B2 |
| 7659233 | Hurley et al. | Feb 2010 | B2 |
| 7666825 | Wagner et al. | Feb 2010 | B2 |
| 7820609 | Soffin et al. | Oct 2010 | B2 |
| 7829514 | Paul et al. | Nov 2010 | B2 |
| 7841036 | Smith | Nov 2010 | B2 |
| 7867505 | Elliott et al. | Jan 2011 | B2 |
| 7928053 | Hecht et al. | Apr 2011 | B2 |
| 7977288 | SenGupta | Jul 2011 | B2 |
| 8007545 | Fujii et al. | Aug 2011 | B2 |
| 8058500 | Sojka et al. | Nov 2011 | B2 |
| 8084407 | Soffin et al. | Dec 2011 | B2 |
| 8088721 | Soffin et al. | Jan 2012 | B2 |
| 8119168 | Johnson | Feb 2012 | B2 |
| 8124063 | Harichian et al. | Feb 2012 | B2 |
| 8158571 | Alonso | Apr 2012 | B2 |
| 8300949 | Xu | Oct 2012 | B2 |
| 8322631 | Richardson et al. | Dec 2012 | B2 |
| 8343469 | Bierganns et al. | Jan 2013 | B2 |
| 8349300 | Wells | Jan 2013 | B2 |
| 8357359 | Woo et al. | Jan 2013 | B2 |
| 8361450 | Johnson et al. | Jan 2013 | B2 |
| 8388699 | Wood | Mar 2013 | B2 |
| 8401304 | Cavallaro et al. | Mar 2013 | B2 |
| 8435501 | Peffly et al. | May 2013 | B2 |
| 8437556 | Saisan | May 2013 | B1 |
| 8491877 | Schwartz et al. | Jul 2013 | B2 |
| 8539631 | Catalfamo et al. | Sep 2013 | B2 |
| 8574561 | Patel et al. | Nov 2013 | B1 |
| 8580725 | Kuhlman et al. | Nov 2013 | B2 |
| 8609600 | Warr | Dec 2013 | B2 |
| 8628760 | Carter et al. | Jan 2014 | B2 |
| 8629095 | Deleersnyder | Jan 2014 | B2 |
| 8653014 | Hilvert | Feb 2014 | B2 |
| 8675919 | Maladen | Mar 2014 | B2 |
| 8679316 | Brunner et al. | Mar 2014 | B2 |
| 8680035 | Kuhlman et al. | Mar 2014 | B2 |
| 8699751 | Maladen | Apr 2014 | B2 |
| 8709337 | Gruenbacher et al. | Apr 2014 | B2 |
| 8709385 | Tamarkin | Apr 2014 | B2 |
| 8741275 | Dente et al. | Jun 2014 | B2 |
| 8741363 | Albrecht et al. | Jun 2014 | B2 |
| 8771765 | Fernandez | Jul 2014 | B1 |
| 8772354 | Williams et al. | Jul 2014 | B2 |
| 8795635 | Tamarkin et al. | Aug 2014 | B2 |
| 8877316 | Hasenoehrl et al. | Nov 2014 | B2 |
| 8883698 | Scheibel et al. | Nov 2014 | B2 |
| 8931711 | Gruenbacher | Jan 2015 | B2 |
| 8980239 | Staudigel et al. | Mar 2015 | B2 |
| 8987187 | Smets et al. | Mar 2015 | B2 |
| 9006162 | Rizk | Apr 2015 | B1 |
| 9186642 | Dihora et al. | Nov 2015 | B2 |
| 9187407 | Koshti et al. | Nov 2015 | B2 |
| 9265727 | Lowenborg | Feb 2016 | B1 |
| 9272164 | Johnson et al. | Mar 2016 | B2 |
| 9296550 | Smith | Mar 2016 | B2 |
| 9308398 | Hutton et al. | Apr 2016 | B2 |
| 9393447 | Zasloff | Jul 2016 | B2 |
| 9428616 | Wagner | Aug 2016 | B2 |
| 9512275 | Wagner | Dec 2016 | B2 |
| 9610239 | Feng | Apr 2017 | B2 |
| 9655821 | Carter et al. | May 2017 | B2 |
| 9662291 | Johnson et al. | May 2017 | B2 |
| 9682021 | Tamarkin et al. | Jun 2017 | B2 |
| 9776787 | Nakajima | Oct 2017 | B2 |
| 9949901 | Zhao et al. | Apr 2018 | B2 |
| 9949911 | Cetti | Apr 2018 | B2 |
| 9968535 | Kitko | May 2018 | B2 |
| 9968537 | Sharma | May 2018 | B2 |
| 9993419 | Glenn, Jr. | Jun 2018 | B2 |
| 9993420 | Glenn, Jr. et al. | Jun 2018 | B2 |
| 10039706 | Meralli et al. | Aug 2018 | B2 |
| 10039939 | Xavier et al. | Aug 2018 | B2 |
| 10113140 | Frankenbach | Oct 2018 | B2 |
| 10182976 | Staudigel | Jan 2019 | B2 |
| 10238685 | Dunn et al. | Mar 2019 | B2 |
| 10265261 | Park et al. | Apr 2019 | B2 |
| 10311575 | Stofel | Jun 2019 | B2 |
| 10392625 | Jin et al. | Aug 2019 | B2 |
| 10426713 | Song | Oct 2019 | B2 |
| 10441519 | Zhao | Oct 2019 | B2 |
| 10552557 | Frankenbach et al. | Feb 2020 | B2 |
| 10610473 | Hertenstein et al. | Apr 2020 | B2 |
| 10653590 | Torres Rivera | May 2020 | B2 |
| 10799434 | Torres Rivera | Oct 2020 | B2 |
| 10842720 | Thompson | Nov 2020 | B2 |
| 10881597 | Lane et al. | Jan 2021 | B2 |
| 10888505 | Johnson | Jan 2021 | B2 |
| 10912732 | Gillis | Feb 2021 | B2 |
| 11116703 | Song et al. | Sep 2021 | B2 |
| 11116704 | Song et al. | Sep 2021 | B2 |
| 11129775 | Song et al. | Sep 2021 | B2 |
| 11334694 | Cetti et al. | May 2022 | B2 |
| 11334695 | Cetti et al. | May 2022 | B2 |
| 20010000467 | Murray | Apr 2001 | A1 |
| 20010006088 | Lyle | Jul 2001 | A1 |
| 20010006621 | Coupe et al. | Jul 2001 | A1 |
| 20010016565 | Bodet et al. | Aug 2001 | A1 |
| 20020012646 | Royce et al. | Jan 2002 | A1 |
| 20020028182 | Dawson | Mar 2002 | A1 |
| 20020037299 | Turowski-Wanke et al. | Mar 2002 | A1 |
| 20020172648 | Hehner et al. | Nov 2002 | A1 |
| 20020193265 | Perron et al. | Dec 2002 | A1 |
| 20020197213 | Schmenger et al. | Dec 2002 | A1 |
| 20030003070 | Eggers et al. | Jan 2003 | A1 |
| 20030008787 | Mcgee et al. | Jan 2003 | A1 |
| 20030022799 | Alvarado et al. | Jan 2003 | A1 |
| 20030049292 | Turowski-Wanke et al. | Mar 2003 | A1 |
| 20030050150 | Tanaka | Mar 2003 | A1 |
| 20030059377 | Riley | Mar 2003 | A1 |
| 20030083210 | Goldberg | May 2003 | A1 |
| 20030108501 | Hofrichter | Jun 2003 | A1 |
| 20030147842 | Restle et al. | Aug 2003 | A1 |
| 20030154561 | Patel | Aug 2003 | A1 |
| 20030161802 | Flammer | Aug 2003 | A1 |
| 20030180238 | Sakurai et al. | Sep 2003 | A1 |
| 20030180246 | Frantz et al. | Sep 2003 | A1 |
| 20030185867 | Kerschner et al. | Oct 2003 | A1 |
| 20030192922 | Ceppaluni et al. | Oct 2003 | A1 |
| 20030202952 | Wells et al. | Oct 2003 | A1 |
| 20030223951 | Geary et al. | Dec 2003 | A1 |
| 20030228272 | Amjad et al. | Dec 2003 | A1 |
| 20040014879 | Denzer et al. | Jan 2004 | A1 |
| 20040064117 | Hammons | Apr 2004 | A1 |
| 20040144863 | Kendrick | Jul 2004 | A1 |
| 20040151793 | Paspaleeva-kuhn et al. | Aug 2004 | A1 |
| 20040157754 | Geary et al. | Aug 2004 | A1 |
| 20040229963 | Stephane | Nov 2004 | A1 |
| 20040234484 | Peffly | Nov 2004 | A1 |
| 20040235689 | Sakai et al. | Nov 2004 | A1 |
| 20050003975 | Browne et al. | Jan 2005 | A1 |
| 20050003980 | Baker | Jan 2005 | A1 |
| 20050020468 | Frantz et al. | Jan 2005 | A1 |
| 20050136011 | Nekludoff | Jun 2005 | A1 |
| 20050152863 | Brautigam | Jul 2005 | A1 |
| 20050192207 | Morgan et al. | Sep 2005 | A1 |
| 20050201967 | Albrecht et al. | Sep 2005 | A1 |
| 20050202984 | Schwartz et al. | Sep 2005 | A1 |
| 20050227902 | Erazo-majewicz et al. | Oct 2005 | A1 |
| 20050233929 | Queen | Oct 2005 | A1 |
| 20050245407 | Ishihara | Nov 2005 | A1 |
| 20050276831 | Dihora | Dec 2005 | A1 |
| 20060002880 | Peffly | Jan 2006 | A1 |
| 20060005333 | Catalfamo et al. | Jan 2006 | A1 |
| 20060009337 | Smith | Jan 2006 | A1 |
| 20060030509 | Modi | Feb 2006 | A1 |
| 20060034778 | Kitano et al. | Feb 2006 | A1 |
| 20060057075 | Arkin et al. | Mar 2006 | A1 |
| 20060057097 | Derici | Mar 2006 | A1 |
| 20060079417 | Wagner | Apr 2006 | A1 |
| 20060079418 | Wagner et al. | Apr 2006 | A1 |
| 20060079419 | Wagner et al. | Apr 2006 | A1 |
| 20060079420 | Wagner et al. | Apr 2006 | A1 |
| 20060079421 | Wagner et al. | Apr 2006 | A1 |
| 20060084589 | Vlad et al. | Apr 2006 | A1 |
| 20060090777 | Hecht et al. | May 2006 | A1 |
| 20060094610 | Yamato et al. | May 2006 | A1 |
| 20060110415 | Gupta | May 2006 | A1 |
| 20060120982 | Derici et al. | Jun 2006 | A1 |
| 20060120988 | Bailey et al. | Jun 2006 | A1 |
| 20060135397 | Bissey-beugras | Jun 2006 | A1 |
| 20060166857 | Surburg et al. | Jul 2006 | A1 |
| 20060171911 | Schwartz et al. | Aug 2006 | A1 |
| 20060183662 | Crotty | Aug 2006 | A1 |
| 20060210139 | Carroll | Sep 2006 | A1 |
| 20060229227 | Goldman | Oct 2006 | A1 |
| 20060252662 | Soffin | Nov 2006 | A1 |
| 20060263319 | Fan et al. | Nov 2006 | A1 |
| 20060276357 | Smith et al. | Dec 2006 | A1 |
| 20060292104 | Guskey | Dec 2006 | A1 |
| 20070003499 | Shen et al. | Jan 2007 | A1 |
| 20070020263 | Shitara et al. | Jan 2007 | A1 |
| 20070072781 | Soffin et al. | Mar 2007 | A1 |
| 20070110700 | Wells | May 2007 | A1 |
| 20070154402 | Trumbore et al. | Jul 2007 | A1 |
| 20070155637 | Smith et al. | Jul 2007 | A1 |
| 20070160555 | Staudigel | Jul 2007 | A1 |
| 20070179207 | Fernandez de Castro et al. | Aug 2007 | A1 |
| 20070225193 | Kuhlman et al. | Sep 2007 | A1 |
| 20070269397 | Terada | Nov 2007 | A1 |
| 20070275866 | Dykstra | Nov 2007 | A1 |
| 20070292380 | Staudigel | Dec 2007 | A1 |
| 20070298994 | Finke et al. | Dec 2007 | A1 |
| 20080003245 | Kroepke et al. | Jan 2008 | A1 |
| 20080008668 | Harichian et al. | Jan 2008 | A1 |
| 20080019928 | Franzke | Jan 2008 | A1 |
| 20080063618 | Johnson | Mar 2008 | A1 |
| 20080138442 | Johnson | Jun 2008 | A1 |
| 20080152610 | Cajan | Jun 2008 | A1 |
| 20080160093 | Schwartz et al. | Jul 2008 | A1 |
| 20080176780 | Warr | Jul 2008 | A1 |
| 20080194454 | Morgan | Aug 2008 | A1 |
| 20080206179 | Peffly et al. | Aug 2008 | A1 |
| 20080260655 | Tamarkin et al. | Oct 2008 | A1 |
| 20080260665 | Guerchet et al. | Oct 2008 | A1 |
| 20080261844 | Ruppert et al. | Oct 2008 | A1 |
| 20080317698 | Wells et al. | Dec 2008 | A1 |
| 20090005280 | Woo et al. | Jan 2009 | A1 |
| 20090029900 | Cetti et al. | Jan 2009 | A1 |
| 20090041702 | Molenda | Feb 2009 | A1 |
| 20090062406 | Loeffler | Mar 2009 | A1 |
| 20090155383 | Kitko et al. | Jun 2009 | A1 |
| 20090178210 | Bistram | Jul 2009 | A1 |
| 20090197784 | Ainger | Aug 2009 | A1 |
| 20090221463 | Kitko et al. | Sep 2009 | A1 |
| 20090240223 | Warren | Sep 2009 | A1 |
| 20090246236 | Kitko | Oct 2009 | A1 |
| 20090312223 | Yang et al. | Dec 2009 | A1 |
| 20090312224 | Yang et al. | Dec 2009 | A1 |
| 20090324505 | Seidling | Dec 2009 | A1 |
| 20100000116 | Aouad et al. | Jan 2010 | A1 |
| 20100001116 | Johnson | Jan 2010 | A1 |
| 20100009285 | Daems et al. | Jan 2010 | A1 |
| 20100061946 | Scherner et al. | Mar 2010 | A1 |
| 20100087357 | Morgan, III et al. | Apr 2010 | A1 |
| 20100152083 | Velazquez | Jun 2010 | A1 |
| 20100168251 | Warr et al. | Jul 2010 | A1 |
| 20100183539 | Bernhardt | Jul 2010 | A1 |
| 20100215775 | Schmaus et al. | Aug 2010 | A1 |
| 20100287710 | Denutte et al. | Nov 2010 | A1 |
| 20100310644 | Liebmann | Dec 2010 | A1 |
| 20100322878 | Stella et al. | Dec 2010 | A1 |
| 20110008267 | Arkin et al. | Jan 2011 | A1 |
| 20110023266 | Gross et al. | Feb 2011 | A1 |
| 20110098209 | Smets et al. | Apr 2011 | A1 |
| 20110107524 | Chieffi et al. | May 2011 | A1 |
| 20110118691 | Nishitani | May 2011 | A1 |
| 20110139170 | Hippe et al. | Jun 2011 | A1 |
| 20110150815 | Woo et al. | Jun 2011 | A1 |
| 20110165107 | Derks et al. | Jul 2011 | A1 |
| 20110171155 | Federle | Jul 2011 | A1 |
| 20110177017 | Coffindaffer et al. | Jul 2011 | A1 |
| 20110232668 | Hoffmann | Sep 2011 | A1 |
| 20110245126 | Tsaur et al. | Oct 2011 | A1 |
| 20110245134 | Smets | Oct 2011 | A1 |
| 20110245136 | Smets | Oct 2011 | A1 |
| 20110268778 | Dihora et al. | Nov 2011 | A1 |
| 20110269657 | Dihora | Nov 2011 | A1 |
| 20110300095 | Dente et al. | Dec 2011 | A1 |
| 20110303766 | Smith | Dec 2011 | A1 |
| 20110305739 | Royce | Dec 2011 | A1 |
| 20110305778 | Caggioni et al. | Dec 2011 | A1 |
| 20110308555 | Smets et al. | Dec 2011 | A1 |
| 20110308556 | Smets et al. | Dec 2011 | A1 |
| 20110319790 | Kost et al. | Dec 2011 | A1 |
| 20120004328 | Huchel et al. | Jan 2012 | A1 |
| 20120009285 | Wei et al. | Jan 2012 | A1 |
| 20120014901 | Sunkel et al. | Jan 2012 | A1 |
| 20120031419 | Batt | Feb 2012 | A1 |
| 20120034173 | Batt | Feb 2012 | A1 |
| 20120052031 | Troccaz et al. | Mar 2012 | A1 |
| 20120100091 | Hata et al. | Apr 2012 | A1 |
| 20120100092 | Murray | Apr 2012 | A1 |
| 20120129924 | Park et al. | May 2012 | A1 |
| 20120219610 | Smith, III et al. | Aug 2012 | A1 |
| 20120230936 | Mikkelsen | Sep 2012 | A1 |
| 20120237469 | Dente et al. | Sep 2012 | A1 |
| 20120246851 | Smith, III et al. | Oct 2012 | A1 |
| 20120258150 | Rauckhorst et al. | Oct 2012 | A1 |
| 20120291911 | Smith | Nov 2012 | A1 |
| 20120309660 | Kawasoe | Dec 2012 | A1 |
| 20120316095 | Wei et al. | Dec 2012 | A1 |
| 20130029932 | Kachi et al. | Jan 2013 | A1 |
| 20130034515 | Stone et al. | Feb 2013 | A1 |
| 20130043145 | Smith, III et al. | Feb 2013 | A1 |
| 20130043146 | Smith, III et al. | Feb 2013 | A1 |
| 20130043147 | Smith, III et al. | Feb 2013 | A1 |
| 20130045285 | Stella et al. | Feb 2013 | A1 |
| 20130053295 | Kinoshita et al. | Feb 2013 | A1 |
| 20130053300 | Scheibel et al. | Feb 2013 | A1 |
| 20130089587 | Staudigel | Apr 2013 | A1 |
| 20130115173 | Trumbore et al. | May 2013 | A1 |
| 20130143784 | Rizk | Jun 2013 | A1 |
| 20130150338 | Ananthapadmanabhan | Jun 2013 | A1 |
| 20130156712 | Frantz | Jun 2013 | A1 |
| 20130189212 | Jawale et al. | Jul 2013 | A1 |
| 20130211952 | Sugaya | Aug 2013 | A1 |
| 20130216491 | Ogihara et al. | Aug 2013 | A1 |
| 20130243718 | Pasquet | Sep 2013 | A1 |
| 20130244922 | Bartelt | Sep 2013 | A1 |
| 20130266642 | Hollingshead et al. | Oct 2013 | A1 |
| 20130280192 | Carter et al. | Oct 2013 | A1 |
| 20130280202 | Stella et al. | Oct 2013 | A1 |
| 20130284195 | Murdock | Oct 2013 | A1 |
| 20130296289 | Hall et al. | Nov 2013 | A1 |
| 20130319463 | Policicchio | Dec 2013 | A1 |
| 20140037703 | Dihora et al. | Feb 2014 | A1 |
| 20140039066 | Grimadell et al. | Feb 2014 | A1 |
| 20140086893 | Gutmann et al. | Mar 2014 | A1 |
| 20140112879 | Molenda et al. | Apr 2014 | A1 |
| 20140127149 | Lepilleur | May 2014 | A1 |
| 20140131395 | Chang | May 2014 | A1 |
| 20140134125 | Dahl | May 2014 | A1 |
| 20140162979 | Palla-venkata | Jun 2014 | A1 |
| 20140171471 | Krueger | Jun 2014 | A1 |
| 20140186864 | Kato et al. | Jul 2014 | A1 |
| 20140201927 | Bianchetti et al. | Jul 2014 | A1 |
| 20140216495 | Bureiko | Aug 2014 | A1 |
| 20140221269 | Sobel et al. | Aug 2014 | A1 |
| 20140228268 | Fahl et al. | Aug 2014 | A1 |
| 20140237732 | Zuedel Fernandes et al. | Aug 2014 | A1 |
| 20140246515 | Nakajima | Sep 2014 | A1 |
| 20140308227 | Mabille | Oct 2014 | A1 |
| 20140309154 | Carter et al. | Oct 2014 | A1 |
| 20140335041 | Peffly et al. | Nov 2014 | A1 |
| 20140348884 | Hilvert et al. | Nov 2014 | A1 |
| 20140348886 | Johnson et al. | Nov 2014 | A1 |
| 20140349902 | Allef et al. | Nov 2014 | A1 |
| 20150017152 | Potechin et al. | Jan 2015 | A1 |
| 20150021496 | Shabbir | Jan 2015 | A1 |
| 20150037273 | Wagner | Feb 2015 | A1 |
| 20150050231 | Murase | Feb 2015 | A1 |
| 20150071977 | Dihora | Mar 2015 | A1 |
| 20150093420 | Snyder | Apr 2015 | A1 |
| 20150093429 | Carter et al. | Apr 2015 | A1 |
| 20150098921 | Franzke et al. | Apr 2015 | A1 |
| 20150099684 | Boutique | Apr 2015 | A1 |
| 20150108163 | Smith et al. | Apr 2015 | A1 |
| 20150110728 | Jayaswal | Apr 2015 | A1 |
| 20150141310 | Smets et al. | May 2015 | A1 |
| 20150147286 | Barrera | May 2015 | A1 |
| 20150157548 | De Feij et al. | Jun 2015 | A1 |
| 20150218496 | Schmiedel et al. | Aug 2015 | A1 |
| 20150231045 | Krohn et al. | Aug 2015 | A1 |
| 20150262354 | Periaswamy | Sep 2015 | A1 |
| 20150297489 | Kleinen et al. | Oct 2015 | A1 |
| 20150299400 | Wagner et al. | Oct 2015 | A1 |
| 20150313818 | Stagg | Nov 2015 | A1 |
| 20150352027 | Thomas et al. | Dec 2015 | A1 |
| 20150359725 | Glenn, Jr. et al. | Dec 2015 | A1 |
| 20150359726 | Glenn, Jr. et al. | Dec 2015 | A1 |
| 20150359728 | Glenn, Jr. et al. | Dec 2015 | A1 |
| 20160008257 | Zhou et al. | Jan 2016 | A1 |
| 20160022566 | Figura | Jan 2016 | A1 |
| 20160089317 | Cetti et al. | Mar 2016 | A1 |
| 20160089318 | Cetti et al. | Mar 2016 | A1 |
| 20160089322 | Santos Nogueira et al. | Mar 2016 | A1 |
| 20160089462 | Frankenbach | Mar 2016 | A1 |
| 20160089464 | Frankenbach et al. | Mar 2016 | A1 |
| 20160089465 | Frankenbach et al. | Mar 2016 | A1 |
| 20160090555 | Frankenbach | Mar 2016 | A1 |
| 20160090556 | Frankenbach et al. | Mar 2016 | A1 |
| 20160090557 | Frankenbach et al. | Mar 2016 | A1 |
| 20160090558 | Frankenbach et al. | Mar 2016 | A1 |
| 20160092661 | Hollingshead et al. | Mar 2016 | A1 |
| 20160095804 | Xavier et al. | Apr 2016 | A1 |
| 20160113849 | Grimadell et al. | Apr 2016 | A1 |
| 20160128944 | Chawrai | May 2016 | A1 |
| 20160193125 | Jones et al. | Jul 2016 | A1 |
| 20160206522 | Ribaut et al. | Jul 2016 | A1 |
| 20160235643 | Mathonneau et al. | Aug 2016 | A1 |
| 20160250115 | Li et al. | Sep 2016 | A1 |
| 20160279048 | Jayaswal et al. | Sep 2016 | A1 |
| 20160287503 | Schroeder | Oct 2016 | A1 |
| 20160287509 | Peffly | Oct 2016 | A1 |
| 20160296656 | Scavone et al. | Oct 2016 | A1 |
| 20160303043 | Khoury | Oct 2016 | A1 |
| 20160306909 | Hollingshead et al. | Oct 2016 | A1 |
| 20160309871 | Torres Rivera et al. | Oct 2016 | A1 |
| 20160310369 | Thompson et al. | Oct 2016 | A1 |
| 20160310370 | Zhao et al. | Oct 2016 | A1 |
| 20160310371 | Zhao | Oct 2016 | A1 |
| 20160310375 | Torres Rivera | Oct 2016 | A1 |
| 20160310386 | Smith, III et al. | Oct 2016 | A1 |
| 20160310388 | Smith, III et al. | Oct 2016 | A1 |
| 20160310389 | Thompson et al. | Oct 2016 | A1 |
| 20160310390 | Smith, III et al. | Oct 2016 | A1 |
| 20160310391 | Smith, III et al. | Oct 2016 | A1 |
| 20160310393 | Chang et al. | Oct 2016 | A1 |
| 20160310402 | Zhao et al. | Oct 2016 | A1 |
| 20160317424 | Kadir et al. | Nov 2016 | A1 |
| 20160326458 | Smets et al. | Nov 2016 | A1 |
| 20160354300 | Thompson et al. | Dec 2016 | A1 |
| 20170066579 | Zillges | Mar 2017 | A1 |
| 20170071837 | Schelges et al. | Mar 2017 | A1 |
| 20170101609 | Vargas | Apr 2017 | A1 |
| 20170110690 | Lamansky et al. | Apr 2017 | A1 |
| 20170110695 | Nishikawa et al. | Apr 2017 | A1 |
| 20170119917 | Frankenbach et al. | May 2017 | A1 |
| 20170137752 | Frankenbach et al. | May 2017 | A1 |
| 20170137753 | Frankenbach et al. | May 2017 | A1 |
| 20170165164 | Zhao et al. | Jun 2017 | A1 |
| 20170165165 | Zhao et al. | Jun 2017 | A1 |
| 20170209359 | Zhao et al. | Jul 2017 | A1 |
| 20170224607 | Li et al. | Aug 2017 | A1 |
| 20170239155 | Hartnett | Aug 2017 | A1 |
| 20170249407 | Cetti et al. | Aug 2017 | A1 |
| 20170249408 | Cetti et al. | Aug 2017 | A1 |
| 20170252273 | Renock et al. | Sep 2017 | A1 |
| 20170255725 | Frankenbach et al. | Sep 2017 | A1 |
| 20170278249 | Stofel | Sep 2017 | A1 |
| 20170283959 | Shellef | Oct 2017 | A1 |
| 20170304172 | Chang et al. | Oct 2017 | A1 |
| 20170304184 | Glenn, Jr. | Oct 2017 | A1 |
| 20170304185 | Glenn, Jr. et al. | Oct 2017 | A1 |
| 20170304186 | Glenn, Jr. | Oct 2017 | A1 |
| 20170333321 | Carnali | Nov 2017 | A1 |
| 20170333591 | Scavone et al. | Nov 2017 | A9 |
| 20170367963 | Kadir et al. | Dec 2017 | A1 |
| 20180004875 | Cetti et al. | Jan 2018 | A1 |
| 20180044097 | Zeik | Feb 2018 | A1 |
| 20180057451 | Owens et al. | Mar 2018 | A1 |
| 20180066210 | Frankenbach et al. | Mar 2018 | A1 |
| 20180110594 | Atkin | Apr 2018 | A1 |
| 20180110688 | Torres Rivera et al. | Apr 2018 | A1 |
| 20180110689 | Torres Rivera et al. | Apr 2018 | A1 |
| 20180110690 | Torres Rivera | Apr 2018 | A1 |
| 20180110691 | Torres Rivera et al. | Apr 2018 | A1 |
| 20180110692 | Torres Rivera et al. | Apr 2018 | A1 |
| 20180110693 | Renock et al. | Apr 2018 | A1 |
| 20180110694 | Renock et al. | Apr 2018 | A1 |
| 20180110695 | Thompson | Apr 2018 | A1 |
| 20180110696 | Johnson et al. | Apr 2018 | A1 |
| 20180110704 | Zhao et al. | Apr 2018 | A1 |
| 20180110707 | Zhao et al. | Apr 2018 | A1 |
| 20180110710 | Zhao et al. | Apr 2018 | A1 |
| 20180110714 | Glenn, Jr. et al. | Apr 2018 | A1 |
| 20180116937 | Park et al. | May 2018 | A1 |
| 20180116941 | Wang | May 2018 | A1 |
| 20180133133 | Kleinen et al. | May 2018 | A1 |
| 20180177708 | Lee et al. | Jun 2018 | A1 |
| 20180221266 | Zhao et al. | Aug 2018 | A1 |
| 20180256475 | Terrisse et al. | Sep 2018 | A1 |
| 20180256481 | Glenn, Jr. | Sep 2018 | A1 |
| 20180280270 | Rughani et al. | Oct 2018 | A1 |
| 20180311135 | Chang | Nov 2018 | A1 |
| 20180311136 | Chang | Nov 2018 | A1 |
| 20180318194 | Hoffmann et al. | Nov 2018 | A1 |
| 20180344611 | Zhao et al. | Dec 2018 | A1 |
| 20180344612 | Zhao et al. | Dec 2018 | A1 |
| 20180344613 | Zhao et al. | Dec 2018 | A1 |
| 20180344614 | Zhao et al. | Dec 2018 | A1 |
| 20180360713 | Jouy et al. | Dec 2018 | A1 |
| 20190105242 | Song | Apr 2019 | A1 |
| 20190105243 | Song et al. | Apr 2019 | A1 |
| 20190105244 | Song | Apr 2019 | A1 |
| 20190105245 | Song | Apr 2019 | A1 |
| 20190105246 | Cochran et al. | Apr 2019 | A1 |
| 20190105247 | Song et al. | Apr 2019 | A1 |
| 20190117543 | Zhao | Apr 2019 | A1 |
| 20190117544 | Zhao | Apr 2019 | A1 |
| 20190117545 | Zhao | Apr 2019 | A1 |
| 20190125650 | Lee et al. | May 2019 | A1 |
| 20190142711 | Torres Rivera | May 2019 | A1 |
| 20190142800 | Ghosh et al. | May 2019 | A1 |
| 20190155975 | Cetti et al. | May 2019 | A9 |
| 20190167554 | Wankhade | Jun 2019 | A1 |
| 20190183777 | Gillis | Jun 2019 | A1 |
| 20190183778 | Glenn, Jr. | Jun 2019 | A1 |
| 20190192405 | Zhao | Jun 2019 | A1 |
| 20190240121 | Torres Rivera | Aug 2019 | A1 |
| 20190307298 | Zhao | Oct 2019 | A1 |
| 20190328647 | Chang et al. | Oct 2019 | A1 |
| 20190365619 | Ceballos et al. | Dec 2019 | A1 |
| 20190365633 | Glenn, Jr. | Dec 2019 | A1 |
| 20200000690 | Renock | Jan 2020 | A1 |
| 20200078284 | Botto et al. | Mar 2020 | A1 |
| 20200129402 | Jamadagni | Apr 2020 | A1 |
| 20200163846 | Song | May 2020 | A1 |
| 20200163860 | Adamy et al. | May 2020 | A1 |
| 20200170894 | Park et al. | Jun 2020 | A1 |
| 20200197272 | Hertenstein et al. | Jun 2020 | A1 |
| 20200206110 | Hertenstein et al. | Jul 2020 | A1 |
| 20200237628 | Torres Rivera | Jul 2020 | A1 |
| 20210022986 | Glenn, Jr. | Jan 2021 | A1 |
| 20210093543 | Parikh et al. | Apr 2021 | A1 |
| 20210121385 | Muller et al. | Apr 2021 | A1 |
| 20210128444 | Muller et al. | May 2021 | A1 |
| 20210128447 | Galpin et al. | May 2021 | A1 |
| 20210169765 | Renock | Jun 2021 | A1 |
| 20210212927 | Hutton, III et al. | Jul 2021 | A1 |
| 20210267853 | Johnson et al. | Sep 2021 | A1 |
| 20210275410 | Hutton, III | Sep 2021 | A1 |
| 20210353518 | Ballhaus et al. | Nov 2021 | A1 |
| 20210353522 | Ballhaus et al. | Nov 2021 | A1 |
| 20210401716 | Gogineni et al. | Dec 2021 | A1 |
| 20220062136 | Feng | Mar 2022 | A1 |
| 20220160606 | Renock | May 2022 | A1 |
| 20220175640 | Herteinstein et al. | Jun 2022 | A1 |
| 20220378680 | Ballhaus et al. | Dec 2022 | A1 |
| 20220378684 | Cochran et al. | Dec 2022 | A1 |
| 20220395444 | Hutton, III | Dec 2022 | A1 |
| 20230053056 | Renock et al. | Feb 2023 | A1 |
| Number | Date | Country |
|---|---|---|
| 825146 | Aug 1975 | BE |
| 199400875 | May 1996 | BR |
| 704195 | Feb 1965 | CA |
| 1248458 | Jan 1989 | CA |
| 2078375 | Mar 1994 | CA |
| 1263455 | Aug 2000 | CN |
| 1286612 | Mar 2001 | CN |
| 1545404 | Nov 2004 | CN |
| 1823929 | Aug 2006 | CN |
| 100534415 | Sep 2009 | CN |
| 101112349 | May 2011 | CN |
| 101690697 | Oct 2011 | CN |
| 101559034 | Jan 2013 | CN |
| 102895151 | Jan 2013 | CN |
| 102973437 | Mar 2013 | CN |
| 102697668 | Aug 2013 | CN |
| 103356408 | Oct 2013 | CN |
| 102697670 | Jul 2014 | CN |
| 104107401 | Oct 2014 | CN |
| 102851015 | Dec 2014 | CN |
| 105726393 | Jul 2016 | CN |
| 105769617 | Jul 2016 | CN |
| 106659664 | May 2017 | CN |
| 106750361 | May 2017 | CN |
| 107595657 | Jan 2018 | CN |
| 107595673 | Jan 2018 | CN |
| 107648096 | Feb 2018 | CN |
| 107737329 | Feb 2018 | CN |
| 108186385 | Jun 2018 | CN |
| 108283583 | Jul 2018 | CN |
| 110279591 | Sep 2019 | CN |
| 2145204 | Mar 1973 | DE |
| 3018456 | Nov 1981 | DE |
| 4315396 | Nov 1994 | DE |
| 102004012009 | Sep 2005 | DE |
| 202005009618 | Sep 2005 | DE |
| 102004023720 | Dec 2005 | DE |
| 102014225083 | Oct 2015 | DE |
| 102014225606 | Oct 2015 | DE |
| 102015204987 | Sep 2016 | DE |
| 0108517 | May 1984 | EP |
| 0574086 | Dec 1993 | EP |
| 0666358 | Aug 1995 | EP |
| 0674898 | Oct 1995 | EP |
| 1340485 | Feb 2003 | EP |
| 1346720 | Sep 2003 | EP |
| 067898 | Mar 2006 | EP |
| 1714678 | Oct 2006 | EP |
| 1842572 | Oct 2007 | EP |
| 2005939 | Dec 2008 | EP |
| 1970045 | Sep 2009 | EP |
| 2042216 | Sep 2015 | EP |
| 3260171 | Dec 2017 | EP |
| 3622946 | Mar 2020 | EP |
| 2052450 | Dec 1994 | ES |
| 2669531 | May 1992 | FR |
| 2795955 | Jan 2001 | FR |
| 190110699 | Aug 1901 | GB |
| 191023922 | Oct 1911 | GB |
| 1347950 | Feb 1974 | GB |
| 2048229 | Dec 1980 | GB |
| 2450727 | Jan 2009 | GB |
| 42318 | Aug 1986 | HU |
| S56011009 | Dec 1981 | JP |
| S58113300 | Jul 1983 | JP |
| S58198412 | Nov 1983 | JP |
| AS60004598 | Jan 1985 | JP |
| S61236708 | Oct 1986 | JP |
| S62205200 | Sep 1987 | JP |
| S63501221 | May 1988 | JP |
| S63165308 | Jul 1988 | JP |
| H04364114 | Dec 1992 | JP |
| H06220495 | Aug 1994 | JP |
| 07252134 | Oct 1995 | JP |
| H08310924 | Nov 1996 | JP |
| 09020618 | Jan 1997 | JP |
| 09030938 | Feb 1997 | JP |
| H09175961 | Jul 1997 | JP |
| H10017894 | Jan 1998 | JP |
| 2964226 | Oct 1999 | JP |
| 2000178586 | Jun 2000 | JP |
| 3069802 | Jul 2000 | JP |
| 2001011492 | Jan 2001 | JP |
| 2001011497 | Jan 2001 | JP |
| 2001254099 | Sep 2001 | JP |
| 2001261529 | Sep 2001 | JP |
| 2003201217 | Dec 2001 | JP |
| 2002179552 | Jun 2002 | JP |
| 2002226889 | Aug 2002 | JP |
| 2002336337 | Nov 2002 | JP |
| 2003055699 | Feb 2003 | JP |
| 2003082398 | Mar 2003 | JP |
| 2003171688 | Jun 2003 | JP |
| 2003176497 | Jun 2003 | JP |
| 2003261413 | Sep 2003 | JP |
| 2003268398 | Sep 2003 | JP |
| 3480165 | Dec 2003 | JP |
| 2003342131 | Dec 2003 | JP |
| 3634988 | Mar 2005 | JP |
| 3634991 | Mar 2005 | JP |
| 3634996 | Mar 2005 | JP |
| 2005187359 | Jul 2005 | JP |
| 2005232113 | Sep 2005 | JP |
| 2006063044 | Mar 2006 | JP |
| 2006104149 | Apr 2006 | JP |
| 2006124312 | May 2006 | JP |
| 2006183039 | Jul 2006 | JP |
| 2006193549 | Jul 2006 | JP |
| 2006249092 | Sep 2006 | JP |
| 2006282565 | Oct 2006 | JP |
| 2007131687 | May 2007 | JP |
| 2007177047 | Jul 2007 | JP |
| 2007223935 | Sep 2007 | JP |
| 2008001626 | Jan 2008 | JP |
| 2008214292 | Sep 2008 | JP |
| 2009096778 | May 2009 | JP |
| 2009120559 | Jun 2009 | JP |
| 2009161866 | Jul 2009 | JP |
| 2011153167 | Aug 2011 | JP |
| 2011190221 | Sep 2011 | JP |
| 2011241353 | Dec 2011 | JP |
| 5041113 | Jul 2012 | JP |
| 2013010757 | Jan 2013 | JP |
| 2013091641 | May 2013 | JP |
| 2013151434 | Aug 2013 | JP |
| 2013155143 | Aug 2013 | JP |
| 2013193968 | Sep 2013 | JP |
| 2013216639 | Oct 2013 | JP |
| 6046394 | Jan 2014 | JP |
| 2014024875 | Feb 2014 | JP |
| 2014037383 | Feb 2014 | JP |
| 2014091723 | May 2014 | JP |
| 2014234350 | Dec 2014 | JP |
| 5667790 | Feb 2015 | JP |
| 2015101545 | Jun 2015 | JP |
| 2015129099 | Jul 2015 | JP |
| 2016013973 | Jan 2016 | JP |
| 2016030722 | Mar 2016 | JP |
| 2016088910 | May 2016 | JP |
| 6184550 | Aug 2017 | JP |
| 2018012673 | Jan 2018 | JP |
| 100290589 | Sep 2001 | KR |
| 100821846 | Apr 2008 | KR |
| 1020080111280 | Dec 2008 | KR |
| 20090095359 | Sep 2009 | KR |
| 20100040180 | Apr 2010 | KR |
| 20140060882 | May 2014 | KR |
| 101494008 | Feb 2015 | KR |
| 101503922 | Mar 2015 | KR |
| 101532070 | Jul 2015 | KR |
| 50333 | May 2010 | UA |
| 8603679 | Jul 1986 | WO |
| 9114759 | Oct 1991 | WO |
| 91017237 | Nov 1991 | WO |
| 9213520 | Aug 1992 | WO |
| 199325650 | Dec 1993 | WO |
| 9417783 | Aug 1994 | WO |
| 9502389 | Jan 1995 | WO |
| 9726854 | Jul 1997 | WO |
| 9823258 | Jun 1998 | WO |
| 9906010 | Feb 1999 | WO |
| 9918928 | Apr 1999 | WO |
| 9924004 | May 1999 | WO |
| 9924013 | May 1999 | WO |
| 9949837 | Oct 1999 | WO |
| 9957233 | Nov 1999 | WO |
| 0012553 | Mar 2000 | WO |
| 0032601 | Jun 2000 | WO |
| 0119949 | Mar 2001 | WO |
| 0142409 | Jun 2001 | WO |
| 0148021 | Jul 2001 | WO |
| 2001076552 | Oct 2001 | WO |
| 2003051319 | Jun 2003 | WO |
| 03096998 | Nov 2003 | WO |
| 2004078901 | Sep 2004 | WO |
| 2005023975 | Mar 2005 | WO |
| 2008017540 | Feb 2008 | WO |
| 2008128826 | Oct 2008 | WO |
| 2008145582 | Dec 2008 | WO |
| 2009016555 | Feb 2009 | WO |
| 2009030594 | Mar 2009 | WO |
| 2009053931 | Apr 2009 | WO |
| 2010026009 | Mar 2010 | WO |
| 2010052147 | May 2010 | WO |
| 2012017091 | Feb 2012 | WO |
| 2012052536 | Apr 2012 | WO |
| 2012055587 | May 2012 | WO |
| 2012055812 | May 2012 | WO |
| 2012084970 | Jun 2012 | WO |
| 2012127009 | Sep 2012 | WO |
| 2012136651 | Oct 2012 | WO |
| 2013010706 | Jan 2013 | WO |
| 2013018805 | Feb 2013 | WO |
| 2013119908 | Aug 2013 | WO |
| 2014073245 | May 2014 | WO |
| 2014073456 | May 2014 | WO |
| 2014111667 | Jul 2014 | WO |
| 2014111668 | Jul 2014 | WO |
| 2014148245 | Sep 2014 | WO |
| 2015067779 | May 2015 | WO |
| 2015085376 | Jun 2015 | WO |
| 2015122371 | Aug 2015 | WO |
| 2015141787 | Sep 2015 | WO |
| 2016049389 | Mar 2016 | WO |
| 2016147196 | Sep 2016 | WO |
| 2017052161 | Mar 2017 | WO |
| 2017140798 | Aug 2017 | WO |
| 2017140802 | Aug 2017 | WO |
| 2017207685 | Dec 2017 | WO |
| 2018023180 | Feb 2018 | WO |
| 2018109148 | Jun 2018 | WO |
| 2019030458 | Feb 2019 | WO |
| 2019074990 | Apr 2019 | WO |
| 2019074992 | Apr 2019 | WO |
| 2019200027 | Oct 2019 | WO |
| 2020005309 | Jan 2020 | WO |
| 2020030732 | Feb 2020 | WO |
| 2021026572 | Feb 2021 | WO |
| 2021099088 | May 2021 | WO |
| 2021127318 | Jun 2021 | WO |
| 2021144326 | Jul 2021 | WO |
| 2021231510 | Nov 2021 | WO |
| Entry |
|---|
| “Personal care solutions Guide”, Solvay, Publication date: May 2018, 84 pages. |
| 15367 Third Party Opposition for 18796213.9 dated Feb. 28, 2023, 23 pages. |
| Product Data Record Tego®Betain F Kb 5, dated Jul. 1, 2015, 4 pages. |
| Shampoo, ID# 6148479, Mintel GNPD [online], URL: http://www.gnpd.com, Nov. 2018, 4 pages. |
| PubChem CID 3033856 for decyl glucoside. downloaded Jun. 22, 2023, 32 pages. (Year: 2023). |
| “Comparative Study on the Chemical constituents of Aloe Vera and Aloe Kula in China”, Zhang Xiaohua et al., Flavor Cosmetics, No. 63, dated Dec. 31, 2000, pp. 7-11. |
| Anonymous: “Anti-Dandruff Scalp Care Shampoo”, Mintel, Database accession No. 301924, Sep. 16, 2004, 2 pages. |
| “Anti-Dandruff Shampoo”, Mintel Database, Record No. 752198, dated Aug. 2007 ; pp. 1-3. |
| “Dandruff Control Shampoo” , Mintel Database, Record No. 2300131, dated Jan. 2014; pp. 1-2. |
| “Foam & chemical contamination in waterways”, Retrieved From https://www.epa.nsw.gov.au/-/media/epa/corporate-site/resources/epa/foam-chemical-contamination-in-waterway.pdf, Dec. 2015, 2 Pages. |
| “Natural Detangling Shampoo”, Mintel Database, dated Sep. 13, 2017; 2 pages. |
| “Soda Shampoo”, Mintel Database, dated Apr. 2015; pp. 1-4. |
| “Treatment Foam for Recurrent Scaling Conditions”, Mintel Database, Aug. 2007; pp. 1-2. |
| 15367 PCT Search Report and Written Opinion for PCT/US2018/055107 dated Jan. 28, 2019, 15 pages. |
| 15367 Third Party Observation for 18796213.9-1112 dated Aug. 4, 2021, 4 pages. |
| 15367D EP Search Report and Written Opinion for 22189741.6 dated Nov. 18, 2022, 10 pages. |
| 15367D2 EP Search Report and Written Opinion for 22189743.2; dated Nov. 18, 2022, 8 pages. |
| Acne Foaming Cleanser, Database accession No. 4172863, Jul. 29, 2016, 3 pages. |
| Air Quality of the lowa Department of Natural Resources. A Review of The Science and Technology of Odor Measurement, 2005, 51 pages (2005). |
| All Office Actions; U.S. Appl. No. 16/156,066, filed Oct. 10, 2018. |
| All Office Actions, U.S. Appl. No. 16/156,072. |
| All Office Actions; U.S. Appl. No. 16/156,072, filed Oct. 10, 2018. |
| All Office Actions; U.S. Appl. No. 17/147,574, filed Jan. 13, 2021. |
| All Office Actions; U.S. Appl. No. 17/320,379, filed May 14, 2021. |
| All Office Actions; U.S. Appl. No. 17/320,391, filed May 14, 2021. |
| All Office Actions; U.S. Appl. No. 18/083,741, filed Dec. 19, 2022. |
| Anonymous: “MERQUAT Polyquaternium 47 Series, Water Soluble Polymers for Personal Care”, Jul. 30, 2017, URL: https://www.in-cosmetics.com/_novadocuments/2729, retrieved on Dec. 21, 2018 ; 1 page. |
| Anonymous: “Naturally Derived Body Wash”, Database GNPD [Online] MINTEL; Feb. 15, 2021, 2 pages. |
| Anonymous: “Peptide Shampoo”, Database Gnpd [Online] MINTEL; Dec. 14, 2015, 3 pages. |
| Anonymous: “Replenishing Moisture Shampoo”, Database GNPD [Online] MINTEL, Mar. 10, 2015br. |
| Anonymous: “Shampoo”, Database GNPD [Online] MINTEL, Jan. 26, 2021, 3 pages. |
| Anonymous: “Shampooing au Phytolait d'abricot—Formule N° 102-MP06-MI3-AA03”,INTERNET CITATION, Feb. 19, 2005, Retrieved from the Internet:URL: http://web.archive.org/web/20050219040350/www.albanmuller.com/francais/catalogue/formules/formul10.asp, 1 page. |
| ASTM D3954-94, Reapproved 2010, vol. 15.04, Standard Test Method for Dropping Point of Waxes. |
| BASF, “Practical Guide to Rheology Modifiers”, download from https://insights.basf.com/files/BASF_ED_RheologyModifiers_download.pdf on Nov. 1, 2022. (Year: 2022). |
| Brattoli et al. Odour Detection Methods: Offactometry and Chemical Sensors. Sensors (Basel), 2011; 11(5); 5290-5322 (2011). |
| Carbopol Aqua SF-1 Polymer Technical Data Sheet, TDS-294, dated Dec. 2000 ; pp. 1-9. |
| Chemical Book (Chemical Book, Isolongifolone, available at http://www.chemicalbook.com/ProductChemicalPropertiesCB5318980_EN.htm), no date available. |
| Christensen et al., “Experimental Determination of Bubble Size Distribution in a Water col. by Interferometric Particle Imaging and Telecentric Direct Image Method”, Student Report, Aalborg University; dated Jun. 3, 2014; 123 pages. |
| Crepaldi, E.L., et al., Chemical, Structural, and Thermal Properties of Zn(II)—Cr(III) Layered Double Hydroxides Intercalated with Sulfated and Sulfonated Surfactants, Journal of Colloid and Interface Science, 2002, pp. 429-442, vol. 248. |
| D'Souza et al., Shampoo and Conditioners: What a Dermatologist Should Know? Indian J Dermatol, dated May-Jun. 2015; pp. 60(3), 248-254 (2015). |
| Database GNPD [Online] MINTEL;Mar. 28, 2018 (Mar. 28, 2018), anonymous: Dandruff Control Shampoo 11,XP055787038, Database accession No. 5556267abstract. |
| Database GNPD [Online] MINTEL;Apr. 5, 2005 (Apr. 5, 2005Apr. 5, ), anonymous: “Anticaspa-Graso Anti-DandruffShampoo”,XPC:I55787029,Database accession No. 351776paragraph [ingredients]. |
| Database GNPD [Online] MINTEL; Jan. 6, 2020 ( Jan. 6, 2020), anonymous: 11 Shampoo 11, 3 pages. |
| Database WPI; Week 201459; Thomson scientific, London, GB; AN 2014-P66521; XP002752638. |
| Datasheet: Empigen Total Active TC/U, Datasheet, dated Jan. 31, 2017 (Innospec) ; 2 pages. |
| Dehyquart Guar: Published dated Nov. 2010 ; pp. 1-34. |
| Fevola, Michael J. “Guar Hydroxypropyltrimonium Chloride.” Cosmetics and toiletries; vol. 127.1; Jan. 2012 ; pp. 16-21. |
| Grillet et al., “Polymer Gel Rheology and Adhesion”, Rheology, 2012, pp. 59-80. |
| Hair Care/Conditioning Polymers Differentiation, Anonymous, Feb. 1, 2017, URL: http://www.biochim.it./assets/site/media/allegati/cosmetica/hair-care/tab-merquat-hair-care.pdf, retrieved on Dec. 20, 2018; p. 1. |
| Happi: “Sulfate-Free Surfactants Conditioning Shampoo”, Retrieved from the Internet: URL:https://www.happi.com/contents/view_formulary/2009-10-01/sulfate-free-surfactants-conditioning-shampoo/, XP002804301, Jan. 10, 2019, 1 page. |
| Inspection certificate for Hostapon® CCG, Clariant Ibérica Production, S.A., May 6, 2019; p. 1-2. |
| McGinley et al. American Association of Textile Chemists and Colorists, 2017, 17 pages, (2017). |
| McGinley et al. Performance Verification of Air Freshener Products and Other Odour Control Devices for Indoor Air Quality Malodours. Presented at the 8th Workshop on Odour and Emissions of Plastic Materials Universitat Kassel Institut for Wesrkstofftechnik Kassel, Germany, 27-28, Mar. 2006, 13 pages. |
| Medvedev, Diffusion Coefficients in Multicomponent Mixtures, PHD Thesis from Technical University of Denmark, dated 2005, 181 pages. |
| Mintel GNPD Base, Bright Blonde Shampoo Record No. 3412889 Feb. 29, 2016 ; 2 pages. |
| Mintel GNPD Base, Mineral Conquer Blonde Silver Shampoo Record No. 3953107 Apr. 30, 2016; 2 pages. |
| Mintel GNPD Base, Royal Treatment Collection, Record No. 1946223 dated Dec. 31, 2011, 3 pages. |
| Morioka, H. et al. “Effects of Zinc on the New Preparation Method of Hydroxy Double Salts” Inorg. Chem. 1999, 38, 4211-6. |
| Musazzi, “Emulsion versus nonoemulsion: how much is the formulative shift critical for a cosmetic product?” (Drug Deliv. and Trans. Res. (2018) 8: pp. 414-421 (Year: 2018). |
| Natural oils: why specific carbon chains are chosen for certain surfactant properties, Chemlink, URL Link: https://www.chemlink.co.uk/natural-oils-why-specific-carbon-chains-are-chosen-for-certain-surfactant-properties/a (Year: 2022), 4 pgs. |
| Naturally Rich Moisturizing Shampoo, Database accession No. 6421011, Mar. 27, 2019, 3 pages. |
| Noritomi H. Formation and Solubilization Property of Water-in-Oil Microemulsions of Alkyl Glucoisdes. Advances in Nanoparticles, 2013, 2, 366-371 (Year: 2013). |
| Parchem fine & specialty chemicals. MIPA-laureth sulfate supplier distributor—CAS 83016-76-6; dated 2021; pp. 1-7. |
| PERM Inc, , Diffusion Coefficient: Measurement Techiques, https://perminc.com/resources/fundamentals-of-fluid-flow-in-porous-media/chapter-3-molecular-diffusion/diffusion-coefficient/measurement-techniques, dated Oct. 2020; p. 1-4. |
| Polyquaternium: “Final Report on the Safety Assessment of the Polyquaternium-10”, Journal of the American College of Toxicology, Jan. 1, 1988, URL: http://www.beauty-review.nl/wp-content/uploads/2015/02/Final-Report-on-the Safety-Assessment-of-Polyquaternium-10.pdf, retrieved on Dec. 20, 2018; 9 pages. |
| Practical Modern Hair Science, Published 2012; 43 pages. |
| Product Bulletin, Amphosol® CG, Cocamidopropyl Betaine, Stepan Company, Jun. 2011; 1-2 pages. |
| Product Data Sheet for Chemoryl™ LS Surfactant, Sodium Lauroyl Sarcosinate, Lubrizol Advanced Materials, Inc., Mar. 24, 2020; 1-2 pages. |
| Product Data Sheet, Eversoft™ UCS-40S, Disodium Cocoyl Glutamate (Sodium Cocoyl Glutamate*), Sino Lion USA, Jul. 2018; 2 pages. |
| Product Fact Sheet—Hostapon® CCG, mild anionic surfactant for the cosmetic industry, Clariant International Ltd., Aug. 2014 ; 1-3 pages. |
| Product Fact Sheet, Hostapon® CGN, Mild anionic surfactant for the cosmetic industry, Clariant International Ltd., Jan. 2016; 1-2 pages. |
| Rajendran A. et al.: “Study on the Analysis of Trace Elements in Aloe veraand Its Biological Importance Study on the Analysis of Trace Elements in Aloe vera and Its Biological Importance”, Journal of Applied Sciences Research, Jan. 1, 2007 (Jan. 1, 2007), XP055799133, pp. 1476-1478. |
| Robinson et al., Final Report of the Amended Safety Assessment of Sodium Laureth Sulfate and Related Salts of SulfatedEthoxylated Alcohols, International Journal of Toxicology 29 (Supplement 3); dated 2010; pp. 151S-161S. |
| S. Herrwerth et al.: “Highly Concentrated Cocamidopropyl Betaine—The Latest Developments for Improved Sustainability and Enhanced Skin Care”, Tenside, Surfactants, Detergents, vol. 45, No. 6, dated Nov. 1, 2008, pp. 304-308, p. 305—left-hand column; 3 pages. |
| Safety assessment of amino acid alkyl amides used in cosmetics , dated Sep. 20, 2013, 46 pages. |
| Schaefer, Katie, “Eco-friendly, Non-flammable Liquified Gas Propellant”, https://www.cosmeticsandtoiletries.com/formulating/function/aids/138418589.html#close-olyticsmodal. Published Jan. 30, 2012; 1-2 pages. |
| Sensory., “A Review of The Science and Technology of Odor Measurement”, Prepared for the Air Quality Bureau of the Iowa Department of Natural Resources, Dec. 30, 2005 51 pages. |
| Shampoo C, Database accession No. 1632217, Sep. 29, 2011, 3 pages. |
| Softazoline CL-R, Kawaken Singapore PTE Ltd. Website printout from http://kawaken.com.sg/softazoline-ch-r//a, accessed on Nov. 30, 2022. |
| Todd et al., Volatile Silicone Fluids for Cosmetics, Cosmetics and Toiletries, vol. 91, pp. 27-32 (Jan. 1976). |
| Unpublished U.S. Appl. No. 18/083,741, filed Dec. 19, 2022 to Brooke Michele Cochran et al. |
| UL Prospector® Product Data Sheet, Plantacare® 818 UP, C8-16 fatty alcohol glucoside, BASF, dated May 21, 2015; 1-3 pages. |
| Unhale Shrikrushna Subhash et al: Formulation and Development of Sulphate Free Shampoo About an Updates andGuidelines of Corona Virus View project health and beauty science View project Rohit Bhavsar Reliance Industries Limited; International Journal for Research inApplied Science & Engineering Technology, Apr. 1, 2020 (Apr. 1, 2020)t XP055842327, DOI: 10.22214, 14 pages. |
| “Deep Image Matting”, Ning Xu et al., Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign, Adobe Research, dated Mar. 10, 2017; 10 pages. |
| Number | Date | Country | |
|---|---|---|---|
| 20230089671 A1 | Mar 2023 | US |
| Number | Date | Country | |
|---|---|---|---|
| 62570377 | Oct 2017 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 16156072 | Oct 2018 | US |
| Child | 17986044 | US |
